<SEC-DOCUMENT>0001493152-22-019765.txt : 20220719
<SEC-HEADER>0001493152-22-019765.hdr.sgml : 20220719
<ACCEPTANCE-DATETIME>20220719091927
ACCESSION NUMBER:		0001493152-22-019765
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20220719
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220719
DATE AS OF CHANGE:		20220719

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celsion CORP
		CENTRAL INDEX KEY:			0000749647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				521256615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15911
		FILM NUMBER:		221090506

	BUSINESS ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648
		BUSINESS PHONE:		(609) 896-9100

	MAIL ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELSION CORP
		DATE OF NAME CHANGE:	19980515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEUNG LABORATORIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:CLSN="http://celsion.com/20220719">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_CLSN_celsion.com_20220719 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20220719_20220719 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0000749647 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:EntityCentralIndexKey">0000749647</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="clsn-20220719.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-07-19to2022-07-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-19</xbrli:startDate>
        <xbrli:endDate>2022-07-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90D_edei--DocumentType_c20220719__20220719_zjCO0HFL2A99"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_905_edei--DocumentPeriodEndDate_c20220719__20220719_zsWrCcBS09E5"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">July 19, 2022</ix:nonNumeric></span> (July 18, 2022)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_909_edei--EntityRegistrantName_c20220719__20220719_zWimLqqp5wx4"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:EntityRegistrantName">CELSION
CORPORATION</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its Charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20220719__20220719_z0T3ZWTjU8r4"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityFileNumber_c20220719__20220719_zQnnuO5akPV6"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:EntityFileNumber">001-15911</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20220719__20220719_zrxUegbU5bx9"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:EntityTaxIdentificationNumber">52-1256615</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
    or other jurisdiction</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
    incorporation)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>File
    Number)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(IRS
    Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20220719__20220719_zb4aJ11xzWVk"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:EntityAddressAddressLine1">997
    Lenox Drive</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressAddressLine2_c20220719__20220719_zfqXxocL20Bd"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressCityOrTown_c20220719__20220719_zQYGVMZ4s9Gb"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:EntityAddressCityOrTown">Lawrenceville</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20220719__20220719_zTL7LmdUbIYe"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressPostalZipCode_c20220719__20220719_zIQ9kL5LUUP"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:EntityAddressPostalZipCode">08648-2311</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address
    of principal executive offices)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Zip
    Code)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--CityAreaCode_c20220719__20220719_zI17BfOj4Jr1"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:CityAreaCode">(609)</ix:nonNumeric></span>
<span id="xdx_903_edei--LocalPhoneNumber_c20220719__20220719_zqHhhLugkQWe"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:LocalPhoneNumber">896-9100</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Registrant&#8217;s
telephone number, including area code)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Former
name or former address, if changed since last report.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--WrittenCommunications_c20220719__20220719_z2NcI3XH6pv"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--SolicitingMaterial_c20220719__20220719_zigByWcoR7u1"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementTenderOffer_c20220719__20220719_zsHGlsyVwLwk"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20220719__20220719_zmONtt1FFJk9"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--Security12bTitle_c20220719__20220719_zuPjWQ6u4S29"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:Security12bTitle">Common
    stock, par value $0.01 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--TradingSymbol_c20220719__20220719_zQQ9sVpjRmP1"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" name="dei:TradingSymbol">CLSN</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_908_edei--SecurityExchangeName_c20220719__20220719_zUNAVKvRpyj5"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Market</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933
(&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_902_edei--EntityEmergingGrowthCompany_c20220719__20220719_zhrrwZ4ilr8b"><ix:nonNumeric contextRef="From2022-07-19to2022-07-19" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    5.02</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure
    of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2022, Celsion Corporation (the &#8220;Company&#8221;) announced that Dr. Corinne Le Goff has been appointed to the positions
of President and Chief Executive Officer of the Company and will serve as a director on the Company&#8217;s Board of Directors (the &#8220;Board&#8221;),
effective as of July 18, 2022. Michael H. Tardugno, the Company&#8217;s current Chairman, President and Chief Executive Officer, will
transition from his current role to the position of Executive Chairman of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Le Goff (age 56) served as Chief Commercial Officer of Moderna, Inc. from January 2021 through January 2022. Dr. Le Goff served as Senior
Vice President and General Manager of the U.S. Business Organization at Amgen, Inc. from March 2019 to January 2021. During her tenure
at Amgen, she also served as Senior Vice President of Global Product Strategy from June 2018 to March 2019, and Senior Vice President
of the Europe Region from June 2015 to May 2018. Dr. Le Goff held various positions within the Roche Group, a publicly traded Swiss multinational
healthcare company, including President of Roche&#8217;s French affiliate from May 2012 to May 2015. Dr. Le Goff served on the board
of directors of the Pacific Council on International Policy from October 2019 to December 2020. Dr. Le Goff also served on the board
of directors of CFAO, a trading company, from October 2014 until October 2020, where she served as a member of the Nomination and Compensation
Committee, the Sustainable Development Committee and the Audit Committee. Dr. Le Goff has served on the board of directors of Longboard
Pharmaceuticals, Inc. since March 2021, where she serves as a member of the Compensation Committee and the Audit Committee. Dr. Le Goff
also a director of Acticor Biotech, and of EuroAPI. Dr. Le Goff received a Pharm. D. from the University Paris V and an M.B.A.
in Marketing from La Sorbonne University, France.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no family relationship between Dr. Le Goff and any other director or executive officer of the Company. There are no transactions between
the Company and Dr. Le Goff disclosable pursuant to Item 404(a) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with her appointment as President and Chief Executive Officer, Dr. Le Goff entered into an employment agreement with the Company
(the &#8220;Le Goff Employment Agreement&#8221;), effective as of July 18, 2022. Pursuant to the Le Goff Employment Agreement, the Company
will pay Dr. Le Goff an initial salary of $624,000 and a signing bonus $50,000. Dr. Le Goff&#8217;s targeted annual performance bonus
is 72% of her annual base salary. Any annual bonus for the year ended December 31, 2022 will be pro-rated. Dr. Le Goff will also receive
(i) an option to purchase 177,000 shares of the Company&#8217;s common stock that will vest with respect to 25% of the subject shares
on July 18, 2023 and the remaining 75% percent will vest in equal quarterly installments thereafter such that the stock option will be
fully vested and exercisable as of the fourth anniversary of July 18, 2022, and (ii) a restricted stock award of 53,000 restricted shares
that will vest on July 18, 2023. Dr. Le Goff will not receive any additional compensation for her service on the Board. The Le Goff Employment
Agreement has no set term of employment. In the event of termination by the Company other than for cause, Dr. Le Goff will receive an
amount equal to one year&#8217;s salary as a severance payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
stock options and restricted shares will be granted outside the Company&#8217;s 2018 Stock Incentive Plan, as an inducement material
to Dr. Le Goff&#8217;s entry into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Dr. Le Goff
will also receive annual reimbursements of up to $75,000 for two years to cover Dr. Le Goff&#8217;s relocation expenses from Massachusetts
to New Jersey, which are subject to a repayment obligation in the event that she leaves the Company within a specified period. The Company
will reimburse Dr. Le Goff for reasonable business expenses and Dr. Le Goff will also receive an annual $12,000 expense allowance, which
will be prorated for 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with his transition to the role of Executive Chairman, Mr. Tardugno entered into an employment agreement (the &#8220;Tardugno
Employment Agreement&#8221; and together with the Le Goff Employment Agreement, the &#8220;Employment Agreements&#8221;), effective as
of July 18, 2022, that supersedes his prior employment agreement with the Company. The Tardugno Employment Agreement has a term ending
on December 31, 2024 with the option for a one year extension. Mr. Tardugno will receive a base salary of $500,000 (prorated to $240,000)
for 2022 and a base salary of $350,000 for 2023 and 2024. Mr. Tardugno will remain eligible for annual performance bonuses and equity
awards and may participate in all compensation and benefit programs generally made available to other senior executives. The Company
will reimburse Mr. Tardugno for all reasonable business expenses. In the event of termination by the Company other than for cause, Mr.
Tardugno will receive an amount equal to one year&#8217;s salary as a severance payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions of the Employment Agreements do not purport to be complete and are qualified in their entirety by the full text
of the Employment Agreements, copies of which are attached to this Current Report on Form 8-K as exhibits 10.1 and 10.2 hereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    7.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulation
    FD Disclosure</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the Company&#8217;s press releases announcing Dr. Le Goff&#8217;s appointment as President and Chief Executive Officer and announcing
the inducement grants are furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall they be
deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly
set forth by specific reference in such a filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    9.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Not Applicable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Not Applicable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Not Applicable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<span style="text-decoration: underline">Exhibits</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br />

    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Employment Agreement between Celsion Corporation and Corinne Le Goff, effective as of July 18, 2022</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm" style="-sec-extract: exhibit">Employment Agreement between Celsion Corporation and Michael H. Tardugno, effective as of July 18, 2022</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press release dated July 19, 2022 announcing appointment</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-2.htm">Press release dated July 19, 2022 announcing inducement grants</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CELSION
    CORPORATION</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    July 19, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jeffrey W. Church</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
    W. Church</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Vice President, Chief Financial Officer and Corporate Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OUwlKXxMSiILkYhel5xiSXdkdrX8pP6yTYmGgWG499wrxExktFU1MlzWZQ4nbNpaWoQSb8ior+gc6W6fgLsl3pWxLLUd3x+YkmPQMbEfLqQTRmuvDFYJBMt5uJpHEQRxEsdQHIT31VPSN1WhtkrWIHUFBVPLCq3kYUo4yRdpaoax6oxsFOkEQj+Y5DdEQRjBkXr5JH4YyPNUeLNxPJExde23pjOWGtjU2LguM6H/9T4eWUlU -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EMPLOYMENT
AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
<B>EMPLOYMENT AGREEMENT </B>(the &ldquo;Agreement&rdquo;) is made and entered into effective as of the 18th day of July 2022 (the &ldquo;Effective
Date&rdquo;), by and between Celsion Corporation, a Delaware corporation (the &ldquo;Company&rdquo;), and Corinne Le Goff<B>, </B>an
individual (the &ldquo;Executive&rdquo;).</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 98.7pt 0pt 97.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WITNESSETH</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>the Company desires to employ the Executive to serve in the capacity as President and Chief Executive Officer of the Company and
to cause the Executive to be nominated to serve as a member of the Board of Directors of the Company (the &ldquo;Board&rdquo;) on the
terms and conditions set forth in this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Executive desires to be employed and serve in such capacities on such terms and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.1pt 0pt 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the premises and the mutual covenants and agreements herein contained, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged by the parties hereto, such parties, intending to be legally
bound, agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Employment
                                            Duties and Acceptance.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.15pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
In accordance with the terms of this Agreement, the Company hereby employs the Executive, for the Employment Period (as
hereinafter defined), to render full-time services to the Company as President and Chief Executive Officer and to perform the
customary duties and bear the customary responsibilities of such positions and such other duties and responsibilities, commensurate
with such positions, as the Executive shall be directed as is customary from time to time by the Board to perform or bear, which
duties and responsibilities shall be consistent with the provisions of the Bylaws of the Company in effect on the date hereof that
relate to or bear upon the duties of the President and Chief Executive Officer, all in accordance with the terms of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
As of the Effective Date, the Executive hereby accepts such employment and agrees to render the services described above, in
accordance with the terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Executive further agrees to accept election and to serve during all or any part of the Employment Period as a director of the
Company without any compensation therefor other than that specified in this Agreement, if appointed or elected to such position by
the Board or the stockholders of the Company. At all times during the Employment Period, the Company shall include the Executive in
the management slate for election as a director at every stockholders&rsquo; meeting at which her term as a director would otherwise
expire. At the request of the Board, following termination of this Agreement, the Executive promptly shall tender her resignation as
a director of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The principal place of employment of the Executive hereunder shall at all times during the Employment Period be in the greater
Princeton, New Jersey area or such other location(s) as may be mutually acceptable to the Executive and the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Notwithstanding anything to the contrary herein, although the Executive shall provide services as a full-time employee, it is
understood that the Executive, with prior notification to the Board, may (1) participate in professional activities; (2) publish
academic articles; (3) support non- competing external research programs; and (4) participate in community and/or philanthropic
activities; and (5) remain on the board of directors of two companies, other than the Company, provided that until December 31,
2022, the Executive may serve on a third board of directors at which date the Executive agrees to terminate such position
(collectively, &ldquo;Permitted Activities&rdquo;); <I>provided, </I>that such Permitted Activities do not interfere with the
Executive&rsquo;s duties or services to the Company. Notwithstanding anything to the contrary contained herein, Executive shall not,
at any particular time after December 31, 2022, serve on more than two boards of directors (or similar governing bodies) of entities
(other than the Company (and its subsidiaries)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Period
                                            of Employment.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
period of the Executive&rsquo;s employment under this Agreement (the &ldquo;Employment Period&rdquo;) shall commence as of the Effective
Date and may be terminated by the Company or the Executive pursuant to Section 6, 7 or 8 of this Agreement, as the case may be. In the
event of a termination of this Agreement and the Executive&rsquo;s employment by either party hereto, the terminating party shall notify
the other party in writing in advance that the Executive&rsquo;s employment is being terminated in accordance with this Agreement and
such notice will specify the type of termination and the facts and circumstances claimed to provide the basis for termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Compensation
                                            and Benefits.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.05pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
As compensation for the services rendered or to be rendered pursuant to this Agreement, the Company will pay the Executive an annual
base salary in the amount of $624,000 (the &ldquo;Base Salary&rdquo;). The Executive&rsquo;s Base Salary hereunder shall be reviewed
in the first quarter of 2024 and at least annually thereafter during the Employment Period for adjustment upward (but not downward)
in the discretion of the Board or the Compensation Committee of the Board. The Executive&rsquo;s Base Salary, as so adjusted, shall
be considered the new Base Salary for all purposes of this Agreement. The Base Salary shall be paid in accordance with the
Company&rsquo;s standard payroll practices applicable to its senior executives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company agrees that the Executive shall be eligible for an annual performance bonus from the Company with respect to each fiscal
year of the Company that ends during the Employment Period, pursuant to the Company&rsquo;s management incentive bonus program, or
policy or practice of the Board or Compensation Committee, in effect from time to time. The Executive&rsquo;s target annual
performance bonus shall be equal to seventy-two percent (72.0%) of the Base Salary, but the actual amount of any such performance
bonus shall be determined by the Board or the Compensation Committee of the Board in its sole and absolute discretion, consistent
with the Company&rsquo;s performance, the Executive&rsquo;s contribution to the Company&rsquo;s performance and the provisions of
any such applicable incentive bonus program, policy or practice; <I>provided, however, </I>that such annual performance bonus shall
not exceed ninety-five percent (95%) of the Base Salary for the fiscal year to which the bonus applies except pursuant to a specific
finding by the Board or the Compensation Committee of the Board that a higher percentage is appropriate. The annual performance
bonus for the Company&rsquo;s 2022 fiscal year shall be prorated from the Effective Date. Any annual performance bonus shall be paid
not later than two and one-half months after the end of the fiscal year to which the bonus relates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company shall pay the Executive a signing bonus of $50,000 (the &ldquo;Signing Bonus&rdquo;) on the first regularly scheduled
payroll date following the Effective Date. If the Executive&rsquo;s employment is terminated due to the Executive&rsquo;s
resignation without Good Reason or by the Company for Cause at any time prior to the first anniversary of the Effective Date, the
Executive will promptly repay the Signing Bonus in full to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
As a material inducement to the Executive accepting employment with the Company, on the first day following the Effective Date and
subject to approval by the Board (or the Compensation Committee of the Board), the Company will grant to the Executive the following
equity awards (the &ldquo;Initial Awards&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) A
stock option to purchase 177,000 shares of the Company&rsquo;s common stock (the &ldquo;Stock Option&rdquo;) outside of the Company&rsquo;s
2018 Stock Incentive Plan, as amended (the &ldquo;Stock Incentive Plan&rdquo;) as an &ldquo;inducement grant&rdquo; (within the meaning
of NASDAQ Listing Rule 5635(c)) having substantially the same terms, definitions and provisions of the Stock Incentive Plan. The Stock
Option will have a per share exercise price equal to the last quoted per share sales price of a share of Company common stock as of the
close of business on the date of grant as reported by NASDAQ. The Stock Option will vest and become exercisable with respect to twenty
five percent (25%) of the shares subject thereto on the first anniversary of the Effective Date and the remaining seventy-five percent
(75%) in equal quarterly installments thereafter, such that the Stock Option will be fully vested and exercisable on the fourth (4th)
anniversary of the Effective Date, subject to the Executive&rsquo;s continued employment with the Company through each applicable vesting
date. The Stock Option shall be subject to the terms and conditions set forth in Section 3(f) and in a stock option agreement to be entered
into by the Company and the Executive, which shall evidence the grant of the Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
A restricted stock award consisting of 53,000 restricted shares of Company common stock (the &ldquo;Restricted Stock Award&rdquo;)
outside of the Stock Incentive Plan as an &ldquo;inducement grant&rdquo; (within the meaning of NASDAQ Listing Rule 5635(c)) having
substantially the same terms, definitions and provisions of the Stock Incentive Plan. The Restricted Stock Award will cliff vest on
the first anniversary of the Effective Date, subject to the Executive&rsquo;s continued employment with the Company through each
such vesting date. The Restricted Stock Award shall be subject to the terms and conditions set forth in Section 3(f) and in a
restricted stock award agreement to be entered into by the Company and the Executive, which shall evidence the grant of the
Restricted Stock Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) In
addition to the Initial Awards, the Company agrees to grant to the Executive, during the Employment Period, at the time of its usual
annual grant to employees for the applicable year, such options and/or other equity awards with respect to shares of the Company&rsquo;s
common stock as the Board or the Compensation Committee of the Board shall determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) In
the event of a Change in Control (as defined in Section 12) of the Company, all options and other equity awards, including the Initial
Awards, granted by the Company to the Executive prior to such event, shall immediately vest and, in the case of options and similar awards,
become and remain fully exercisable through their respective original maximum terms (provided that, after giving effect to such accelerated
vesting and providing the Executive a reasonable opportunity to exercise such vested options and similar awards, such options and awards
shall remain subject to the terms of the applicable plan and/or award agreement in connection with a Change in Control and similar events
as provided therein) and otherwise in accordance with their respective terms and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) The
Company shall pay or reimburse the Executive for all reasonable expenses actually incurred or paid by the Executive during the Employment
Period in the performance of services under this Agreement, upon presentation of expense statements or vouchers or such other supporting
information as may reasonably be required pursuant to the standard policies of the Company in effect from time to time. The Executive
agrees to promptly submit and document any reimbursable expenses in accordance with the Company&rsquo;s expense reimbursement policies
to facilitate the timely reimbursement of such expenses. Additionally, the Executive shall receive a $12,000 annual allowance to be used
at the Executive&rsquo;s discretion; with respect to fiscal year 2022, the Executive shall receive $5,490.41 of such allowance on or
around the Effective Date and for future fiscal years, such allowance shall be payable immediately following the date of the Company&rsquo;s
annual meeting of stockholders. The $12,000 allowance will be grossed up for tax purposes at the rate of 25%. Such allowance and related
tax gross-up shall be paid not later than two and one-half months after the end of the year to which the allowance relates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.1pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) During
the Employment Period, the Company shall, at its election, provide the Executive with term life insurance at a level equal to one (1)
times her Base Salary, or provide coverage for the Executive at such level.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.1pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) During
the Employment Period, the Executive shall be eligible to participate in all qualified and non-qualified savings and retirement plans,
and all other compensation and benefit plans and programs, including welfare and fringe benefit programs, that are generally made available
by the Company to other senior executives of the Company, in each case in accordance with the eligibility and participation provisions
of such plans and programs and as such plans or programs may be in effect from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) The
Executive shall be eligible for paid vacation of three (3) weeks for calendar year 2022 and five (5) weeks per calendar year beginning
in 2023 and thereafter during the Employment Period, in each case, to be taken in accordance with the vacation policy of the Company
as in effect from time to time. Under the current vacation policy, in the event that Executive does not utilize all of her vacation in
any calendar year, she may carry forward up to two (2) weeks (ten (10) days) for up to one (1) calendar year, and unused vacation days
shall not otherwise accumulate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) During
the Employment Period, Executive will relocate her primary residence to the New Jersey area within a reasonable period of time following
the Effective Date and, in connection with such relocation, (i) the Company will reimburse the Executive for amounts not to exceed $75,000
annually for the rental cost of a leasing accommodation and related temporary living in the New Jersey area during the period in which
the Executive retains her primary residence in the Massachusetts area but not to exceed two years from the Effective Date, and (ii) in
the event of a sale of the Executive&rsquo;s existing primary residence in the Massachusetts area, the Company will reimburse the Executive
for reasonable costs incurred for the relocation of the Executive&rsquo;s personal goods to the New Jersey area, with such reimbursement
payment for the relocation of personal goods to be grossed up for federal and state income taxes, if applicable, in each case, subject
to the Executive&rsquo;s presentation of expense statements or vouchers or such other supporting information as may reasonably be required
pursuant to the standard policies of the Company in effect from time to time. Any such reimbursement payments and, solely with respect
to clause (ii), any tax gross-up payment shall be paid not later than two and one-half months after the end of the year to which the
payment relates. If the Executive&rsquo;s employment is terminated due to the Executive&rsquo;s resignation without Good Reason or by
the Company for Cause, in either case, at any time prior to the second anniversary of the Effective Date, the Executive will promptly
repay in full to the Company all monies provided to the Executive under the foregoing clauses (i) and (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Confidentiality.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Executive acknowledges and agrees that the &ldquo;Employee Proprietary Information and Ownership of Inventions Agreement&rdquo; annexed
hereto as <U>Exhibit A</U> shall be deemed incorporated in and made a part of this Employment Agreement. Notwithstanding any other provision
of this Agreement, the Executive shall continue to be bound by the terms of such Proprietary Information and Inventions Agreement for
a period of five (5) years after the termination of this Agreement and the Executive&rsquo;s employment for any reason. The Executive
and the Company agree that following termination of the Executive&rsquo;s employment and this Agreement for any reason the Proprietary
Information and Inventions Agreement shall be applicable only to material, non-public, proprietary information of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Non-Competition,
                                            Non-Solicitation and Non-Disparagement.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) During
the Employment Period, the Executive shall not (1) provide any services, directly or indirectly, to any other business or commercial
entity without the consent of the Board or (2) participate in the formation of any business or commercial entity without the consent
of the Board; <I>provided, however</I>, that nothing contained in this Section 5(a) shall be deemed to prohibit the Executive from acquiring,
solely as an investment, shares of capital stock (or other interests) of any corporation (or other entity) not exceeding two percent
(2%) of such corporation&rsquo;s (or other entity&rsquo;s) then-outstanding shares of capital stock (or other interests) and, <I>provided
further</I>, that nothing contained herein shall be deemed to limit the Executive&rsquo;s Permitted Activities pursuant to Section 1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) If
the Executive&rsquo;s employment and this Agreement is terminated by the Company for Cause (as defined in Section 6(c)) or if the Executive
terminates employment and this Agreement pursuant to Section 7(b) hereof, or if the Executive is entitled to receive severance payments
in connection with a termination of her employment in accordance with Section 9(c)(i) or 9(d)(i), then for a period of two (2) years
following the date of termination the Executive shall not (1) provide any services, directly or indirectly, to any other business or
commercial entity in the Company&rsquo;s Field of Interest (as defined in Section 12), (2) attempt to persuade or encourage customers
or suppliers of the Company not to do business with the Company and/or to do business with a competitor of the Company, (3) participate
in the formation of any business or commercial entity engaged primarily in the Company&rsquo;s Field of Interest, or (4) directly or
indirectly employ, or seek to employ or secure the services in any capacity of, any person employed at that time by the Company or any
of its Affiliates, or otherwise encourage or entice any such person to leave such employment; provided, however, that nothing contained
in this Section 5(b) shall be deemed to prohibit the Executive from acquiring, solely as an investment, shares of capital stock (or other
interests) of any corporation (or other entity) in the Company&rsquo;s Field of Interest not exceeding two percent (2%) of such corporation&rsquo;s
(or other entity&rsquo;s) then outstanding shares of capital stock (or other interests) and, provided further, that nothing contained
herein shall be deemed to limit Executive&rsquo;s Permitted Activities pursuant to Section 1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.05pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) At
no time during the Employment Period or thereafter will the Executive knowingly make any written or oral untrue statement or any statement
that disparages the Company or its Affiliates or will the Company knowingly make any written or oral untrue statement or any statement
that disparages the Executive. Notwithstanding this provision, the Executive may confer in confidence with her legal representatives
and make truthful statements as required by law or valid subpoena.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) If
the Executive commits a breach, or threatens to commit a breach, of any of the provisions of this Section 5 or <U>Exhibit A</U>, the
Company shall have the right and remedy to have the provisions of this Agreement or <U>Exhibit A</U>, as the case may be, specifically
enforced by any court having equity jurisdiction, it being acknowledged and agreed that any such breach or threatened breach will cause
irreparable injury to the Company and that money damages will not provide an adequate remedy to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) If
any of the covenants contained in this Section 5 or <U>Exhibit A</U> or any part hereof or thereof, is hereafter construed to be invalid,
illegal or unenforceable by a court or regulatory agency or tribunal of competent jurisdiction, such court, agency or tribunal shall
have the power, and hereby is directed, to substitute for or limit such provision(s) in order as closely as possible to effectuate the
original intent of the parties with respect to such invalid, illegal or unenforceable covenant(s) generally and so to enforce such substituted
covenant(s). Subject to the foregoing, the invalidity, illegality or unenforceability of any one or more of the covenants contained in
this Section 5 shall not affect the validity of any other provision hereof, which shall be given full effect without regard to the invalid
portions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) If
any of the covenants contained in this Section 5 or <U>Exhibit A</U>, or any part hereof or thereof, is held to be unenforceable because
of the duration of such provision, the area covered thereby or the extent thereof, the parties hereto agree that the tribunal making
such determination shall have the power, and hereby is directed, to reduce the duration, area and/or extent of such provision and, in
its reduced form, such provision shall then be enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) Anything
else contained in this Agreement to the contrary notwithstanding, the parties hereto intend to and hereby do confer jurisdiction to enforce
the covenants contained in this Section 5 and <U>Exhibit A</U> upon the courts of any state within the geographical scope of such covenants.
In the event that the courts of any one or more of such states shall hold any such covenant wholly unenforceable by reason of the breadth
of such scope or otherwise, it is the intention of the parties hereto that such determination not bar or in any way affect the Company&rsquo;s
right to the relief provided above in the courts of any other state within the geographical scope of such other covenants, as to breaches
of such covenants in such other jurisdictions, the above covenants as they relate to each state being, for this purpose, severable into
diverse and independent covenants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Termination
                                            by the Company.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the Employment Period, the Company may terminate this Agreement and the Executive&rsquo;s employment if any one or more of the following
shall occur:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify; text-indent: -12.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Executive shall die during the Employment Period; <I>provided, however</I>, that the Executive&rsquo;s legal representatives, heirs and estate shall be entitled to receive (1) the Executive&rsquo;s Base Salary through the date which is ninety (90) days after the Executive&rsquo;s date of death and (2) a pro rata annual performance bonus (prorated by multiplying the full year bonus that otherwise would be due by the percentage derived from dividing the number of days in the then-current year prior to the death of the Executive by three hundred sixty-five (365) with respect to the fiscal year of the Company during which death occurs). Upon the Executive&rsquo;s death, stock options previously granted to the Executive that are vested and fully exercisable at the time of death shall remain fully exercisable, by the Executive&rsquo;s legal representatives, through their respective original maximum terms (provided that such options shall remain subject to the terms of the applicable plan and/or award agreement in connection with a Change in Control and similar events as provided therein) and otherwise in accordance with their respective terms and conditions. All stock options and stock awards (and similar equity rights) that have not vested prior the date of death shall be forfeited.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
Executive shall become physically or mentally disabled so that the Executive is unable substantially to perform her services with or
without a reasonable accommodation required by law, hereunder for a period of one hundred twenty (120) consecutive days, or (2) shorter
periods aggregating one hundred eighty (180) days during any twelve (12) month period; <I>provided, however</I>, that the Company may
terminate the Executive&rsquo;s employment under this Section 6(b) only upon thirty (30) days&rsquo; prior written notice given by the
Company to the Executive. Notwithstanding such disability the Company shall continue to pay the Executive her Base Salary through the
date of such termination. In addition, the Executive shall be entitled to a pro rata annual performance bonus (prorated by multiplying
the full year bonus that otherwise would be due by the percentage derived from dividing the number of days in the then-current year prior
to the termination on account of disability of the Executive by three hundred sixty-five (365) with respect to the fiscal year of the
Company during which such termination occurs). Upon such a disability, stock options previously granted to the Executive that are vested
and fully exercisable at the time of disability shall remain fully exercisable, by the Executive or her legal representatives, should
she have such, through their respective original maximum terms (provided that such options shall remain subject to the terms of the applicable
plan and/or award agreement in connection with a Change in Control and similar events as provided therein) and otherwise in accordance
with their respective terms and conditions. All stock options and stock awards (and similar equity rights) that have not vested prior
to the date of disability shall be forfeited by the Executive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) The
Executive acts, or fails to act, in a manner that provides Cause for termination. For purposes of this Agreement, the term &ldquo;Cause&rdquo;
means (1) the Executive&rsquo;s indictment for, or conviction of, any crime or serious offense involving money or other property that
constitutes a felony in the jurisdiction involved; (2) the Executive&rsquo;s willful and ongoing neglect of, or failure to discharge,
duties (including fiduciary duties) responsibilities and obligations with respect to the Company hereunder, provided such willful and
ongoing neglect or failure remains uncured for a period of thirty (30) days after written notice describing the same in reasonable detail
is given to the Executive by the Company; (3) the Executive&rsquo;s violation of any of the restrictive covenants set forth in Section
5 hereof or the Executive&rsquo;s material breach of any provisions of Section 14 hereof or <U>Exhibit A</U> hereto; or (4) any act of
fraud or embezzlement by the Executive involving the Company or any of its Affiliates. All determinations of Cause for termination pursuant
to this Section 6 shall be made by the Board, and shall require at least a two-thirds (2/3) vote of the entire Board excluding the Executive,
should she then be a member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) The
Company terminates this Agreement and the Executive&rsquo;s employment for any reason other than for Cause.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Termination
                                            by the Executive.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Good Reason</U>. The Executive may terminate this Agreement and the Executive&rsquo;s employment hereunder and this Agreement for
Good Reason. For purposes of this Agreement, &ldquo;Good Reason&rdquo; means the occurrence, without the Executive&rsquo;s written consent
of any of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) any
material adverse change in the Executive&rsquo;s authority, duties or responsibilities, titles or offices (including reporting responsibility);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) a
material reduction in the Executive&rsquo;s Base Salary or target annual performance bonus opportunity;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
a material breach by the Company of its obligations under this Agreement; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the failure of the Company to obtain the assumption in writing of its obligation to perform this Agreement by any successor to all or
substantially all of the assets of the Company upon a merger, consolidation, sale or similar transaction;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provided,
that the Executive&rsquo;s termination shall only constitute a termination for Good Reason if (x) the Executive provides the Company
with written notice detailing the specific condition alleged to constitute Good Reason within 30 days after the initial occurrence of
such condition, (y) the Company fails to cure such condition within 30 days after the Company&rsquo;s receipt of such notice, and (z)
the date of the Executive&rsquo;s termination of employment occurs within 30 days following the expiration of the Company&rsquo;s cure
period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
termination of this Agreement and the Executive&rsquo;s employment hereunder by the Executive pursuant to this Section 7(a) due to the
occurrence of any of the events specified herein shall only be effective if such event also results in a material change to the employment
relationship between the Executive and the Company (or any successor thereto). The foregoing provision is intended to qualify under Treasury
Regulation Section 1.409A-1(n)(2)(i) as an involuntary separation from service and shall be determined in a manner consistent therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Without Good Reason</U>. The Executive may terminate this Agreement and the Executive&rsquo;s employment hereunder without Good Reason
at any time by providing 30 days&rsquo; advance written notice to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Termination
                                            by the Executive for Good Reason Following a Change in Control.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the above, during the period commencing on the six (6) month anniversary of a Change in Control and ending on the one (1)
year anniversary of such Change in Control (the &ldquo;Change in Control Protection Period&rdquo;), the Executive may terminate employment
and this Agreement if &ldquo;Good Reason&rdquo; exists for the Executive&rsquo;s termination pursuant to Section 7(a) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Severance
                                            and Benefit Continuation.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <I>Termination
for Cause or Termination Without Good Reason by the Executive</I>. If the Company terminates this Agreement and the Executive&rsquo;s
employment for Cause pursuant to Section 6(c) hereof, or if the Executive terminates employment without Good Reason pursuant to Section
7(b), no severance or benefit continuation provisions shall apply; provided, however, that the Executive shall have the same opportunity
to continue group health benefits at the Executive&rsquo;s expense in accordance with the Consolidated Omnibus Budget Reconciliation
Act of 1985 (&ldquo;COBRA&rdquo;) as is available generally to other employees terminating employment with the Company. All stock options
and stock awards (and similar equity rights) held by the Executive that have vested prior to such termination of this Agreement may be
exercised by the Executive for a period of one hundred eighty (180) days after the date of termination (provided that such stock options
and awards (and similar equity rights) shall remain subject to the terms of the applicable plan and/or award agreement in connection
with a Change in Control and similar events as provided therein), at which time they shall automatically be forfeited if not exercised.
All stock options and stock awards (and similar equity rights) that have not vested prior to such termination shall be forfeited by the
Executive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <I>Termination
for Death or Disability</I>. In the event of termination of the Executive&rsquo;s employment and this Agreement pursuant to Section 6(a)
or 6(b) by reason of the death or disability of the Executive, in addition to the Base Salary payments and pro rata annual performance
bonus provided for in paragraph (a) or (b) of Section 6, as applicable, the Company shall continue to provide all benefits subject to
COBRA, at its sole cost and expense, with respect to the Executive and her dependents for the maximum period provided by COBRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <I>Termination
by the Company Other Than for Cause or Termination by the Executive for Good Reason Outside of the Change in Control Protection Period</I>.
If (1) the Company terminates this Agreement and the Executive&rsquo;s employment other than for Cause pursuant to Section 6(d) or (2)
the Executive terminates this Agreement and her employment for Good Reason pursuant to Section 7(a), and, in either case, such termination
does not occur during the Change in Control Protection Period, then, subject to Section 9(e):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) the
Company shall pay the Executive in accordance with its normal payroll practice an amount equal to the Executive&rsquo;s Base Salary at
the annualized rate in effect on the date of such termination, such payment to be made in equal monthly installments (rounded down to
the nearest whole cent) over a period of nine (9) consecutive months following the Executive&rsquo;s Separation from Service (as defined
in Section 12) (the &ldquo;Severance Period&rdquo;), with the first installment payable, subject to Section 15, in the month following
the month in which the Executive&rsquo;s Release is effective;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) all
Company employee benefit plans and programs (including, but not limited to, the plans and programs set forth in Section 3(i)), other
than participation in any Company tax-qualified retirement plan and any bonus, equity or other incentive plans and programs, applicable
to the Executive shall be continued for the Severance Period (or, if such benefits are not available, or cannot be provided due to applicable
law, the Company shall pay the Executive a lump sum cash amount equal to the after-tax economic equivalent thereof, provided that, with
respect to any benefit to be provided on an insured basis, such lump sum cash value shall be the present value of the premiums expected
to be paid for such coverage, and with respect to other benefits, such value shall be the present value of the expected cost to the Company
of providing such benefits, and that, in all events, such payment shall be made within ninety (90) days following the Executive&rsquo;s
Separation from Service). Notwithstanding the foregoing, if the Executive becomes re-employed with another employer during the Severance
Period and is eligible to receive comparable group health insurance coverage under another employer&rsquo;s plans, the Company&rsquo;s
obligations under this Section shall be reduced to the extent comparable coverage is actually provided to the Executive and her dependents,
and any such coverage shall be promptly reported by the Executive to the Company. In the case of all benefits subject to COBRA, the Company
shall continue to provide such benefits at its expense with respect to the Executive and her dependents for the maximum period provided
by COBRA; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
all stock options and awards of restricted stock (and similar equity rights), to the extent outstanding and vested on the date of such
termination of this Agreement, shall remain fully exercisable through their respective original maximum terms (provided that such stock
options and awards (and similar equity rights) shall remain subject to the terms of the applicable plan and/or award agreement in connection
with a Change in Control and similar events as provided therein) and otherwise in accordance with their respective terms and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <I>Termination
by the Company Other Than for Cause or Termination by the Executive Based for Good Reason During the Change in Control Protection Period</I>.
If (1) the Company terminates this Agreement and the Executive&rsquo;s employment other than for Cause pursuant to Section 6(d) or (2)
the Executive terminates this Agreement and her employment for Good Reason pursuant to Section 7(a), and, in either case, such termination
occurs at any time during the Change in Control Protection Period, then, subject to Section 9(e):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) the
Company shall pay the Executive a cash lump sum equal to nine months of the Executive&rsquo;s Base Salary at the annualized rate in effect
on the date of such termination, such payment to be made, subject to Section 15, in the month following the month in which the Executive&rsquo;s
Release is effective;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) all
Company employee benefit plans and programs (including, but not limited to, the plans and programs set forth in Section 3(i), other than
participation in any Company tax-qualified retirement plan) applicable to the Executive shall be continued for the Severance Period (or,
if such benefits are not available, or cannot be provided due to applicable law, the Company shall pay the Executive a lump sum cash
amount equal to the after-tax economic equivalent thereof, provided that, with respect to any benefit to be provided on an insured basis,
such lump sum cash value shall be the present value of the premiums expected to be paid for such coverage, and with respect to other
benefits, such value shall be the present value of the expected cost to the Company of providing such benefits and that, in all events,
such payment shall be made within ninety (90) days following the Executive&rsquo;s Separation from Service). Notwithstanding the foregoing,
if the Executive becomes re-employed with another employer during the Severance Period and is eligible to receive comparable group health
insurance coverage under another employer&rsquo;s plans, the Company&rsquo;s obligations under this Section shall be reduced to the extent
comparable coverage is actually provided to the Executive and her dependents, and any such coverage shall be promptly reported by the
Executive to the Company. In the case of all benefits subject to COBRA, the Company shall continue to provide such benefits at its sole
cost and expense with respect to the Executive and her dependents for the maximum period provided by COBRA; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
all stock options and awards of restricted stock (and similar equity rights), to the extent then vested and outstanding (after giving
effect to any accelerated vesting pursuant to Section 3(f) hereof), shall remain fully exercisable through their respective original
maximum terms (provided that, after giving effect to such accelerated vesting and providing the Executive a reasonable opportunity to
exercise such vested options and similar awards, such options and awards shall remain subject to the terms of the applicable plan and/or
award agreement in connection with a Change in Control and similar events as provided therein) and otherwise in accordance with their
respective terms and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) As
a condition of receiving the payments provided for in Section 9(c) or 9(d), as applicable, the Executive or her legal representatives,
should she have such, shall first execute and deliver to the Company within twenty-one (21) days (or such other period required under
applicable law) following such termination of employment a general release of all claims against the Company, its Affiliates, agents
and employees (other than any claims or rights pursuant to the Agreement or pursuant to equity or employee benefit plans), in a form
and substance satisfactory to the Company, and shall not revoke such release within any revocation period provided under applicable law
(the &ldquo;Release Period&rdquo;). In connection with such release by the Executive, the Company shall execute and deliver a comparable
release of claims against the Executive within the same time period following such termination of employment, and may revoke such release
if the Executive revokes her release within any revocation period provided under applicable law. Notwithstanding the foregoing, the Executive
may elect to forego the severance payments provided herein, in which event neither party hereto shall be required to execute a release
of the other. Notwithstanding the foregoing provisions of this Section 9(e), no release to be granted by the Executive shall be required
to cause the Executive to release the Company from, waive, or forego in any way any of the Executive&rsquo;s rights to indemnification
under the applicable provisions of the Certificate of Incorporation or By-laws of the Company or any then-existing agreement between
the Company and the Executive with respect thereto; and no release to be granted by the Company hereunder shall apply to any obligation
of the Executive pursuant to this Agreement or any act of fraud or material dishonesty by the Executive. Further, the Company acknowledges
and agrees that the Release will not include any confidentiality or non-competition, non-solicitation and non-disparagement covenants
on the Executive that exceed the scope and/or duration of those covenants set forth in Sections 4 and 5, respectively, hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cooperation.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the termination of her employment, the Executive agrees to cooperate with, and assist, the Company to ensure a smooth transition in management
and, if requested by the Company, to make herself available to consult at mutually agreed upon times for up to a nine (9) month period
thereafter. At any time following the termination of her employment, the Executive will provide such information as the Company may reasonably
request with respect to any Company- related transaction or other matter in which the Executive was involved in any way while employed
by the Company. The Executive further agrees, during the Employment Period and thereafter, to assist and cooperate with the Company in
connection with the defense or prosecution of any claim that may be made against, or by, the Company or its Affiliates, in connection
with any dispute or claim of any kind involving the Company or its Affiliates, including providing testimony in any proceeding before
any arbitral, administrative, judicial, legislative or other body or agency. The Executive shall be entitled to reimbursement for all
properly documented expenses reasonably incurred in connection with rendering transition services under this Section, including, but
not limited to, reimbursement for all reasonable travel, lodging, meal expenses and reasonable legal fees, and the Executive shall be
entitled to a per diem amount for her services equal to her then most recent annualized Base Salary under this Agreement, divided by
two hundred forty (240) (business days).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mitigation.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Executive shall not be required to mitigate the amount of any payment provided for hereunder by seeking other employment or otherwise,
nor shall the amount of any payment provided for hereunder be reduced by any compensation earned by the Executive as the result of employment
by another employer after the date of termination of employment by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Definitions.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used herein, the following terms have the following meaning:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &ldquo;Affiliate&rdquo;
means and includes any person, corporation or other entity controlling, controlled by or under common control with the person, corporation
or other entity in question, determined in accordance with Rule 12b-2 under the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &ldquo;Change
in Control&rdquo; means the occurrence of any of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.15pt 0pt 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Any
Person, other than the Company, its Affiliates or any Company employee benefit plan (including any trustee of such plan acting as trustee),
is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing more than fifty percent (50%) of
the combined voting power of the then outstanding securities entitled to vote generally in the election of directors (&ldquo;Voting Securities&rdquo;)
of the Company; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) Individuals
who constitute the Board (the &ldquo;Incumbent Directors&rdquo;), as of the beginning of any twenty-four (24) month period commencing
with the Effective Date of this Agreement, cease for any reason to constitute at least a majority of the directors. Notwithstanding the
foregoing, any individual becoming a director subsequent to the beginning of such period, whose election or nomination for election by
the Company&rsquo;s stockholders, was approved by a vote of at least two-thirds (2/3) of the directors then comprising the Incumbent
Directors, shall be, considered an Incumbent Director; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.85pt 0pt 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) Consummation
by the Company of a recapitalization, reorganization, merger, consolidation or other similar transaction (a &ldquo;Business Combination&rdquo;),
with respect to which all or substantially all of the individuals and entities who were the Beneficial Owners of the Voting Securities
immediately prior such Business Combination (the &ldquo;Incumbent Shareholders&rdquo;) do not, following consummation of all transactions
intended to constitute part of such Business Combination, Beneficially Own, directly or indirectly, fifty percent (50%) or more of the
Voting Securities of the corporation, business trust or other entity resulting from or being the surviving entity in such Business Combination
(the &ldquo;Surviving Entity&rdquo;), in substantially the same proportion as their ownership of such Voting Securities immediately prior
to such Business Combination; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 48.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) Consummation
of a complete liquidation or dissolution of the Company, or the sale or other disposition of all or substantially all of the assets of
the Company, other than to a corporation, business trust or other entity with respect to which, following consummation of all transactions
intended to constitute part of such sale or disposition, more than fifty percent (50%) of the combined Voting Securities is then Beneficially
Owned, directly or indirectly, by the Incumbent Shareholders in substantially the same proportion as their ownership of the Voting Securities
immediately prior to such sale or disposition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this definition, the following terms shall have the meanings set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.05pt; text-indent: -14.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Beneficial
                                            Owner&rdquo; shall have the meaning set forth in Rule 13d-3 under the Exchange Act;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.05pt; text-indent: -14.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Exchange
                                            Act&rdquo; shall mean the Securities Exchange Act of 1934, as amended; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52.05pt; text-indent: -14.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Person&rdquo;
                                            shall have the meaning as used in Sections 13(d) and 14(d) of the Exchange Act.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.05pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a transaction shall not constitute a Change in Control unless it is a &ldquo;change in the ownership or effective control&rdquo;
of the Company, or a change &ldquo;in the ownership of a substantial portion of the assets&rdquo; of the Company within the meaning of
Section 409A of the U.S. Internal Revenue Code of 1986, as amended (&ldquo;Code Section 409A&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &ldquo;Company&rsquo;s
Field of Interest&rdquo; means the primary businesses of the Company as such business is being conducted, or actively contemplated, by
the Company, as determined from time to time by the Board, during the Employment Period, including, with respect to such business: (i)
any technology, product, drug or device for which the Company has filed patents, including any technology, product, drug or device that
is a spinoff of any Company patents either filed or actively contemplated to be filed (or otherwise in process), (ii) any technology,
product, drug or device for which the Company has invested resources, (iii) any technology, product, drug or device that the Company
is actively contemplating entering into, engaging in, or acquiring or (iv) any technology, product, drug or device that the Company is
then currently developing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) As
used herein, a &ldquo;Separation from Service&rdquo; occurs when the Executive dies, retires, or otherwise has a termination of employment
with the Company that constitutes a &ldquo;separation from service&rdquo; within the meaning of Treasury Regulation Section 1.409A-1(h)(1),
without regard to the optional alternative definitions available thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representations
                                            by Executive.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Executive represents and warrants that she has full right, power and authority to execute this Agreement and perform her obligations
hereunder and that this Agreement has been duly executed by the Executive and such execution and the performance of this Agreement by
the Executive do not and will not result in any conflict, breach or violation of or default under any other agreement or any judgment,
order or decree to which the Executive is a party or by which she is bound. The Executive acknowledges and agrees that any material breach
of the representations set forth in this Section 13 will constitute Cause under Section 6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Tax
                                            Withholding</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may withhold from any amounts payable under this Agreement (such as Federal, state, or foreign taxes) as shall be required to
be withheld pursuant to any applicable law or regulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
                                            409A Compliance</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.05pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) It
is intended that any amounts payable under this Agreement shall either be exempt from or comply with Code Section 409A (including the
Treasury regulations and other published guidance relating thereto) so as not to subject the Executive to payment of any additional tax,
penalty or interest imposed under Code Section 409A. The provisions of this Agreement shall be construed and interpreted to avoid the
imputation of any such additional tax, penalty or interest under Code Section 409A yet preserve (to the nearest extent reasonably possible)
the intended benefit payable to the Executive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) If
the Executive is a &ldquo;specified employee&rdquo; within the meaning of Treasury Regulation Section 1.409A-1(i) as of the date of the
Executive&rsquo;s Separation from Service, the Executive shall not be entitled to any payment or benefit pursuant to Section 9(c) or
9(d) until the earlier of (i) the date which is six (6) months after her Separation from Service for any reason other than death, or
(ii) the date of the Executive&rsquo;s death. The provisions of this Section 15(b) shall only apply if, and to the extent, required to
avoid the imputation of any tax, penalty or interest pursuant to Code Section 409A. Any amounts otherwise payable to the Executive upon
or in the six (6) month period following the Executive&rsquo;s Separation from Service that are not so paid by reason of this Section
15(b) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six
(6) months after the Executive&rsquo;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty
(30) days, after the date of the Executive&rsquo;s death).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) To
the extent that any benefits pursuant to Section 9(c)(ii) or 9(d)(ii) or reimbursements pursuant to Section 3 are taxable to the Executive,
any reimbursement payment due to the Executive pursuant to any such provision shall be paid to the Executive on or before the last day
of the Executive&rsquo;s taxable year following the taxable year in which the related expense was incurred. The benefits and reimbursements
pursuant to such provisions are not subject to liquidation or exchange for another benefit and the amount of such benefits and reimbursements
that the Executive receives in one taxable year shall not affect the amount of such benefits or reimbursements that the Executive receives
in any other taxable year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Notwithstanding
anything to the contrary in this Agreement, to the extent required to comply with Code Section 409A, a termination of employment shall
not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of amounts or benefits upon
or following a termination of employment unless such termination is also a &ldquo;separation from service&rdquo; within the meaning of
Code Section 409A and, for purposes of any such provision of this Agreement, references to a &ldquo;resignation,&rdquo; &ldquo;termination,&rdquo;
&ldquo;termination of employment&rdquo; or like terms shall mean separation from service. For purposes of Section 409A of the Code, each
payment made under this Agreement shall be designated as a &ldquo;separate payment&rdquo; within the meaning of the Section 409A of the
Code. Notwithstanding anything to the contrary in this Agreement, to the extent required to comply with Code Section 409A, if the Release
Period spans two calendar years, any severance payments to which the Executive may be entitled pursuant to Section 9(c) or 9(d) d shall
be paid on the first regularly scheduled payroll date that occurs in the second calendar year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Arbitration.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties shall attempt in good faith to resolve all claims, disputes and other disagreements arising hereunder by negotiation. In the
event that a dispute between the parties cannot be resolved within thirty (30) days of written notice from one party to the other party,
such dispute shall, at the request of either party, after providing written notice to the other party, be submitted to arbitration in
Lawrenceville, New Jersey in accordance with the arbitration rules of the American Arbitration Association (&ldquo;AAA&rdquo;) then in
effect. The notice of arbitration shall specifically describe the claims, disputes or other matters in issue to be submitted to arbitration.
The parties shall jointly select a single arbitrator who shall have the authority to hold hearings and to render a decision in accordance
with the arbitration rules of the AAA. If the parties are unable to agree within ten (10) days, the arbitrator shall be selected by AAA
directly The discovery rights and procedures provided by the Federal Rules of Civil Procedure shall be available and enforceable in the
arbitration proceeding. The written decision of the arbitrator so appointed shall be conclusive and binding on the parties and enforceable
by a court of competent jurisdiction. The expenses of the arbitration shall be borne equally by the parties to the arbitration, and each
party shall pay for and bear the cost of its or her own experts, evidence and legal counsel, unless the arbitrator rules otherwise in
the arbitration. Each party agrees to use its or her best efforts to cause a final decision to be rendered with respect to the matter
submitted to arbitration within sixty (60) days after its submission. Notwithstanding the foregoing, the Company shall be free to pursue
its rights and remedies under Section 5 hereof and pursuant to <U>Exhibit A</U> hereto in any court of competent jurisdiction, without
regard to the arbitral proceedings contemplated by this Section 16.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notices.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
notices, requests, consents and other communications required or permitted to be given hereunder or contemplated or in connection herewith
shall be in writing and shall be deemed to have been duly given if sent by private overnight mail service (delivery confirmed by such
service), registered or certified mail (return receipt requested and received), or if delivered personally, as follows (or to such other
address as either party shall designate by notice in writing to the other in accordance herewith):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celsion
Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
Lenox Drive, Suite 100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
NJ 08648</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 318.05pt 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Chairman of the Compensation Committee Telephone: 609-896-9100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
Email: MTardugno@celsion.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt; text-indent: -34.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt; text-indent: -34.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
copies to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Baker
&amp; McKenzie LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">452
Fifth Avenue</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Steven G. Canner</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 318.05pt 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
212-626-4884</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
Steven.Canner@BakerMcKenzie.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Executive:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corinne
Le Goff</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: right"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Indemnification
                                            and Limitation of Liability.</U></FONT></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the protections afforded by Article Ninth of the Amended and Restated Certificate of Incorporation,
as may be amended from time to time, of the Company, and Article VI of the Amended and Restated Bylaws, as may be amended from time to
time, of the Company are available to the Executive throughout the Employment Period and thereafter, in accordance with their respective
terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt; text-indent: -15.1pt"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>General.</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.25pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) This
Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New Jersey applicable to agreements
made and to be performed entirely in New Jersey.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) This
Agreement, together with the agreement set forth in Exhibit A hereto and the agreements reflecting the Initial Awards, sets forth the
entire agreement and understanding of the parties hereto relating to the subject matter hereof, and supersedes all prior agreements,
arrangements and understandings, written or oral, relating to the subject matter hereof, including without limitation the Offer Letter
between the Company and the Executive, dated May 16, 2022. No representation, promise or inducement has been made by either party hereto
that is not embodied in this Agreement, and neither party hereto shall be bound by or liable for any alleged representation, promise
or inducement not so set forth. Notwithstanding the foregoing, in the event that the provisions hereof shall conflict with the terms
of any stock option grant agreement, stock award agreement or similar document granting stock options, warrants or similar rights, then
the terms of this Agreement shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) This
Agreement may be amended, modified, superseded, canceled, renewed or extended, and the terms or covenants hereof may be waived, only
by a written instrument executed by the parties hereto, or in the case of a waiver, by the party hereto waiving compliance. The failure
of a party hereto at any time or times to require performance of any provision hereof shall in no manner affect the right at a later
time to enforce the same. No waiver by a party hereto of the breach of any term or covenant contained in this Agreement, whether by conduct
or otherwise, or any one or more or continuing waivers of any such breach, shall constitute a waiver of the breach of any other term
or covenant contained in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 37.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) This
Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective legal representatives, heirs, distributees,
successors and permitted assigns. The Company may not assign its rights and obligation under this Agreement without the prior written
consent of the Executive, except to a successor to substantially all the Company&rsquo;s business that expressly assumes the Company&rsquo;s
obligations hereunder in writing. For purposes of this Agreement, &ldquo;successors&rdquo; shall mean any successor by way of share exchange,
merger, consolidation, reorganization or similar transaction, or the sale of all or substantially all of the assets of the Company. The
Executive may not assign, transfer, alienate or encumber any rights or obligations under this Agreement, except by will or operation
of law, <I>provided </I>that the Executive may designate beneficiaries to receive any payments permitted under the terms of the Company&rsquo;s
benefit plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page follows.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 98.7pt 0pt 97.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, each of the parties has executed this Agreement under its or her seal effective as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CELSION
    CORPORATION</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Michael H. Tardugno</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    H. Tardugno&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman of the Board of Directors</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Corinne Le Goff</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corinne Le Goff</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
page to Employment Agreement]</I></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employee
Proprietary Information and Ownership of Inventions Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Attached)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: NewSection Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-1</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EMPLOYMENT
AGREEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
<B>EMPLOYMENT AGREEMENT</B> (the &ldquo;Agreement&rdquo;) is made and entered into effective as of the 18th day of July 2022 (the &ldquo;Effective
Date&rdquo;), by and between Celsion Corporation, a Delaware corporation (the &ldquo;Company&rdquo;), and Michael H. Tardugno<B>,</B>
an individual (the &ldquo;Executive&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WITNESSETH</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the parties hereto previously entered into that certain Amended and Restated Employment Agreement, effective as of March 30, 2016 (the
&ldquo;Prior Employment Agreement&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the parties hereto now desire to enter into this Agreement, which shall supersede and replace the Prior Employment Agreement in its entirety
effective as of the Effective Date, and the Prior Agreement shall terminate, not be renewed, and have no further force or effect as of
the Effective Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>the Company desires to retain the Executive to serve in the capacity of Executive Chairman of the Board of Directors of the Company
on the terms and conditions set forth in this Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Executive desires to accept employment in such capacity on such terms and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the premises and the mutual covenants and agreements herein contained, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged by the parties hereto, such parties, intending to be legally
bound, agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Employment
    Duties and Acceptance</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
In accordance with the terms of this Agreement, the Company hereby employs the Executive, for the Term (as hereinafter defined), to render
service to the Company as Executive Chairman of the Board of Directors and to perform the customary duties and bear the customary responsibilities
of such position and such other duties and responsibilities, commensurate with such position, as the Executive shall be directed from
time to time by the Board of Directors of the Company (the &ldquo;Board&rdquo;) to perform or bear, which duties and responsibilities
shall be consistent with the provisions of the Bylaws of the Company in effect on the date hereof that relate to or bear upon the duties
of the Executive Chairman of the Board of Directors, all in accordance with the terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
As of the Effective Date, the Executive hereby accepts such employment and agrees to render the services described above, in accordance
with the terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Executive further agrees to accept election and to serve during all or any part of the Term as a director of the Company without
any compensation therefor other than that specified in this Agreement, if elected to such position by the Board or the stockholders of
the Company. At all times during the Term, the Company shall include the Executive in the management slate for election as a director
at every stockholders&rsquo; meeting at which his term as a director would otherwise expire. At the request of the Board, following termination
or expiration of this Agreement, the Executive promptly shall tender his resignation as a director of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The principal place of employment of the Executive hereunder shall at all times during the Term be in the Lawrenceville, New Jersey area
or such other location(s) as may be mutually acceptable to the Executive and the Board. The Executive will maintain a residence in New
Jersey and will file New Jersey tax returns so long as the Company remains eligible for New Jersey State Economic Development incentives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Notwithstanding anything to the contrary herein, although the Executive shall provide services as an employee, it is understood that
the Executive may (1)&nbsp;participate in professional activities; (2)&nbsp;publish academic articles; (3)&nbsp;support non-competing
external research programs; and (4)&nbsp;participate in community and/or philanthropic activities (collectively, &ldquo;Permitted Activities&rdquo;),
<I>provided,</I> that such Permitted Activities do not interfere with the Executive&rsquo;s duties or services to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Term
    of Employment</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
initial term of the Executive&rsquo;s employment under this Agreement (the &ldquo;Term&rdquo;) shall commence on the Effective Date and
shall end on the December 31, 2024, unless sooner terminated by the Company or the Executive pursuant to Section&nbsp;6, 7 or 8 of this
Agreement, as the case may be, or voluntarily by the Executive. Notwithstanding the foregoing, unless notice is given by the Executive
or the Company to the other at least three (3)&nbsp;months prior to the expiration of the Term of this Agreement (including at least
three (3)&nbsp;months prior to the expiration of any extension hereof, as provided below), the Term automatically shall be extended by
one (1)&nbsp;year from the date it would otherwise end (whether upon expiration of the initial Term or any extension(s) thereof), unless
sooner terminated pursuant to Section&nbsp;6, 7 or 8 hereof or voluntarily by the Executive. In the event of such an automatic extension,
the term &ldquo;Term,&rdquo; as used herein, shall include each and any such extension.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Compensation
    and Benefits</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
As compensation for the services rendered or to be rendered pursuant to this Agreement, the Company shall pay the Executive an annual
base salary (the &ldquo;Base Salary&rdquo;), which, during the period from the Effective Date through and including December 31, 2022
shall be in the amount of $500,000 (the actual amount payable during such partial period in 2022 will be $240,000), and, during the period
from January 1, 2023 through and including December 31, 2024 shall be in the amount of $350,000. The Executive&rsquo;s Base Salary hereunder
shall be reviewed at least annually during the Term of the Agreement for adjustment upward (but not downward) in the discretion of the
Board. The Executive&rsquo;s Base Salary, as so adjusted, shall be considered the new Base Salary for all purposes of this Agreement.
The Base Salary shall be paid in accordance with the Company&rsquo;s standard payroll practices applicable to its senior executives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company agrees that the Executive shall be eligible for an annual performance bonus from the Company with respect to each fiscal
year of the Company that ends during the Term, pursuant to the Company&rsquo;s management incentive bonus program, or policy or practice
of the Board or Compensation Committee of the Board, in effect from time to time. The amount of any such performance bonus shall be determined
by the Board or the Compensation Committee of the Board in its sole and absolute discretion, consistent with the Company&rsquo;s performance,
the Executive&rsquo;s contribution to the Company&rsquo;s performance and the provisions of any such applicable incentive bonus program,
policy or practice; <I>provided, however,</I> that such annual performance bonus shall not exceed one hundred percent (100%)&nbsp;of
the Base Salary for the fiscal year to which the bonus applies except pursuant to a specific finding by the Board that a higher percentage
is appropriate. Any such annual performance bonus shall be paid not later than two and one-half months after the end of the fiscal year
to which the bonus relates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company agrees to grant to the Executive, during the Term, at the time of its usual annual grant to employees for the applicable
year, such options and/or other equity awards with respect to shares of the Company&rsquo;s common stock as the Board or the Compensation
Committee of the Board shall determine. In the event of a Change in Control (as defined in Section&nbsp;12) of the Company, all such
options and other equity awards granted by the Company to the Executive prior to such event, shall immediately vest and, in the case
of options and similar awards, become and remain fully exercisable through their respective original maximum terms (provided that, after
giving effect to such accelerated vesting and providing the Executive a reasonable opportunity to exercise such vested options and similar
awards, such options and awards shall be subject to earlier termination in connection with a Change in Control and similar events as
provided in the applicable plan and/or award agreement) and otherwise in accordance with their respective terms and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company shall pay or reimburse the Executive for all reasonable expenses actually incurred or paid by the Executive during the Term
in the performance of services under this Agreement, upon presentation of expense statements or vouchers or such other supporting information
as may reasonably be required pursuant to the standard policies of the Company in effect from time to time. The Executive agrees to promptly
submit and document any reimbursable expenses in accordance with the Company&rsquo;s expense reimbursement policies to facilitate the
timely reimbursement of such expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
During the Term, the Company shall, at its election, reimburse the Executive for term life insurance at a level equal to one (1)&nbsp;times
his Base Salary, or provide coverage for the Executive at such level.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
During the Term, the Executive shall be eligible to participate in all qualified and non-qualified savings and retirement plans, and
all other compensation and benefit plans and programs, including welfare and fringe benefit programs that are generally made available
by the Company to other senior executives of the Company, in each case, in accordance with the eligibility and participation provisions
of such plans and programs and as such plans or programs may be in effect from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
During the Term, the Executive shall be eligible for paid vacation of eight (8)&nbsp;weeks per calendar year taken in accordance with
the vacation policy of the Company. In the event that Executive does not utilize all of his vacation in any calendar year, he may carry
forward up to five (5)&nbsp;weeks (twenty-five (25)&nbsp;days) for up to one (1)&nbsp;calendar year. Unused vacation days shall not otherwise
accumulate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Confidentiality</U>.
    </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Executive acknowledges and agrees that the &ldquo;Employee Proprietary Information and Ownership of Inventions Agreement&rdquo; annexed
hereto as Exhibit A, previously signed by the Executive, will continue in full force and effect pursuant to its terms, and shall be deemed
incorporated in and made a part of this Agreement. Notwithstanding any other provision of this Agreement, the Executive shall continue
to be bound by the terms of such Proprietary Information and Inventions Agreement for a period of five (5)&nbsp;years after the expiration
or termination of this Agreement for any reason. The Executive and the Company agree that following expiration or termination of this
Agreement for any reason the Proprietary Information and Inventions Agreement shall be applicable only to material, non-public, proprietary
information of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Non-Competition,
    Non-Solicitation and Non-Disparagement</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
During the Term, the Executive shall not (1)&nbsp;provide any services, directly or indirectly, to any other business or commercial entity
without the consent of the Board or (2)&nbsp;participate in the formation of any business or commercial entity without the consent of
the Board; <I>provided, however</I>, that nothing contained in this Section&nbsp;5(a) shall be deemed to prohibit the Executive from
acquiring, solely as an investment, shares of capital stock (or other interests) of any corporation (or other entity) not exceeding five
percent (5%)&nbsp;of such corporation&rsquo;s (or other entity&rsquo;s) then-outstanding shares of capital stock (or other interests)
and, <I>provided further</I>, that nothing contained herein shall be deemed to limit the Executive&rsquo;s Permitted Activities pursuant
to Section&nbsp;1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If this Agreement is terminated by the Company for Cause (as defined in Section&nbsp;6(c)) or if the Executive terminates this Agreement
other than in accordance with Section&nbsp;7 or 8 hereof, or if the Executive is entitled to receive severance payments in connection
with a termination of his employment in accordance with Section&nbsp;9(c)(i) or 9(d)(i), then for a period of two (2)&nbsp;years following
the date of termination the Executive shall not (1)&nbsp;provide any services, directly or indirectly, to any other business or commercial
entity in the Company&rsquo;s Field of Interest (as defined in Section&nbsp;12), (2)&nbsp;solicit any customers or suppliers of the Company,
(3)&nbsp;attempt to persuade or encourage customers or suppliers of the Company not to do business with the Company and/or to do business
with a competitor of the Company, (4)&nbsp;participate in the formation of any business or commercial entity engaged primarily in the
Company&rsquo;s Field of Interest, or (5)&nbsp;directly or indirectly employ, or seek to employ or secure the services in any capacity
of, any person employed at that time by the Company or any of its Affiliates, or otherwise encourage or entice any such person to leave
such employment; provided, however, that nothing contained in this Section&nbsp;5(b) shall be deemed to prohibit the Executive from acquiring,
solely as an investment, shares of capital stock (or other interests) of any corporation (or other entity) in the Company&rsquo;s Field
of Interest not exceeding two percent (2%)&nbsp;of such corporation&rsquo;s (or other entity&rsquo;s) then outstanding shares of capital
stock (or other interests) and, provided further, that nothing contained herein shall be deemed to limit Executive&rsquo;s Permitted
Activities pursuant to Section&nbsp;1(e). This Section&nbsp;5(b) shall be subject to written waivers, which may be obtained by the Executive
from the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
At no time during the Term of this Agreement or thereafter will the Executive knowingly make any written or oral untrue statement or
any statement that disparages the Company or its Affiliates or will the Company knowingly make any written or oral untrue statement or
any statement that disparages the Executive. Notwithstanding this provision, the Executive may confer in confidence with his legal representatives
and make truthful statements as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If the Executive commits a breach, or threatens to commit a breach, of any of the provisions of this Section&nbsp;5 or Exhibit A, the
Company shall have the right and remedy to have the provisions of this Agreement or Exhibit A, as the case may be, specifically enforced
by any court having equity jurisdiction, it being acknowledged and agreed that any such breach or threatened breach will cause irreparable
injury to the Company and that money damages will not provide an adequate remedy to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
If any of the covenants contained in this Section&nbsp;5 or Exhibit A or any part hereof or thereof, is hereafter construed to be invalid,
illegal or unenforceable by a court or regulatory agency or tribunal of competent jurisdiction, such court, agency or tribunal shall
have the power, and hereby is directed, to substitute for or limit such provision(s) in order as closely as possible to effectuate the
original intent of the parties hereto with respect to such invalid, illegal or unenforceable covenant(s) generally and so to enforce
such substituted covenant(s). Subject to the foregoing, the invalidity, illegality or unenforceability of any one or more of the covenants
contained in this Section&nbsp;5 shall not affect the validity of any other provision hereof, which shall be given full effect without
regard to the invalid portions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
If any of the covenants contained in this Section&nbsp;5 or Exhibit A, or any part hereof or thereof, is held to be unenforceable because
of the duration of such provision, the area covered thereby or the extent thereof, the parties hereto agree that the tribunal making
such determination shall have the power, and hereby is directed, to reduce the duration, area and/or extent of such provision and, in
its reduced form, such provision shall then be enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Anything else contained in this Agreement to the contrary notwithstanding, the parties hereto intend to and hereby do confer jurisdiction
to enforce the covenants contained in this Section&nbsp;5 and Exhibit A upon the courts of any state within the geographical scope of
such covenants. In the event that the courts of any one or more of such states shall hold any such covenant wholly unenforceable by reason
of the breadth of such scope or otherwise, it is the intention of the parties hereto that such determination not bar or in any way affect
the Company&rsquo;s right to the relief provided above in the courts of any other state within the geographical scope of such other covenants,
as to breaches of such covenants in such other jurisdictions, the above covenants as they relate to each state being, for this purpose,
severable into diverse and independent covenants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Termination
    by the Company</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the Term of this Agreement, the Company may terminate this Agreement if any one or more of the following shall occur: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Executive shall die during the Term; <I>provided, however</I>, that the Executive&rsquo;s legal representatives shall be entitled
to receive (1)&nbsp;the Executive&rsquo;s Base Salary through the date which is ninety (90)&nbsp;days after the Executive&rsquo;s date
of death and (2)&nbsp;a pro rata annual performance bonus (prorated by multiplying the full year bonus that otherwise would be due by
the percentage derived from dividing the number of days in the then-current year prior to the death of the Executive by three hundred
sixty-five (365)&nbsp;with respect to the fiscal year of the Company during which death occurs). Upon the Executive&rsquo;s death, stock
options previously granted to the Executive that are vested and fully exercisable at the time of death shall remain fully exercisable,
by the Executive&rsquo;s legal representatives, through their respective original maximum terms (subject to earlier termination in connection
with a Change in Control and similar events as provided in the applicable plan and/or award agreement) and otherwise in accordance with
their respective terms and conditions. All stock options and stock awards (and similar equity rights) that have not vested prior the
date of death shall be forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Executive shall become physically or mentally disabled so that the Executive is unable substantially to perform his services hereunder
for (1)&nbsp;a period of one hundred twenty (120)&nbsp;consecutive days, or (2)&nbsp;shorter periods aggregating one hundred eighty (180)&nbsp;days
during any twelve (12)&nbsp;month period; <I>provided, however</I>, that the Company may terminate the Executive&rsquo;s employment under
this Section 6(b) only upon thirty (30)&nbsp;days&rsquo; prior written notice given by the Company to the Executive. Notwithstanding
such disability the Company shall continue to pay the Executive his Base Salary through the date of such termination. In addition, the
Executive shall be entitled to a pro rata annual performance bonus (prorated by multiplying the full year bonus that otherwise would
be due by the percentage derived from dividing the number of days in the then-current year prior to the termination on account of disability
of the Executive by three hundred sixty-five (365)&nbsp;with respect to the fiscal year of the Company during which such termination
occurs). Upon such a disability, stock options previously granted to the Executive that are vested and fully exercisable at the time
of disability shall remain fully exercisable, by the Executive or his legal representatives, should he have such, through their respective
original maximum terms (subject to earlier termination in connection with a Change in Control and similar events as provided in the applicable
plan and/or award agreement) and otherwise in accordance with their respective terms and conditions. All stock options and stock awards
(and similar equity rights) that have not vested prior to the date of disability shall be forfeited by the Executive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Executive acts, or fails to act, in a manner that provides Cause for termination. For purposes of this Agreement, the term &ldquo;Cause&rdquo;
means (1)&nbsp;the Executive&rsquo;s indictment for, or conviction of, any crime or serious offense involving money or other property
that constitutes a felony in the jurisdiction involved; (2)&nbsp;the Executive&rsquo;s willful and ongoing neglect of, or failure to
discharge, duties (including fiduciary duties), responsibilities and obligations with respect to the Company hereunder, <I>provided</I>
such neglect or failure remains uncured for a period of thirty (30)&nbsp;days after written notice describing the same is given to the
Executive by the Company; (3)&nbsp;the Executive&rsquo;s violation of any of the non-competition provisions of Section&nbsp;5 hereof
or the Executive&rsquo;s material breach of any provisions of Section&nbsp;13 hereof or Exhibit A hereto, or (4)&nbsp;any act of fraud
or embezzlement by the Executive involving the Company or any of its Affiliates. All determinations of Cause for termination pursuant
to this Section&nbsp;6 shall be made by the Board and shall require at least a two-thirds (2/3)&nbsp;vote of the entire Board excluding
the Executive, should he then be a member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Termination
    by the Executive</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Executive may terminate this Agreement on written notice to the Company in the event of a material breach of the terms of this Agreement
by the Company if such breach continues uncured for thirty (30)&nbsp;days after written notice describing the breach is first given by
the Executive to the Company; <I>provided, however</I>, that the Executive may terminate this Agreement if such breach is for the payment
of money and continues uncured for ten (10)&nbsp;days after written notice describing such breach is first given by the Executive. The
Executive may also terminate this Agreement upon written notice to the Company if any one or more of the following shall occur:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
loss of material duties or authority of the Executive as Executive Chairman of the Board of Directors of the Company, and such loss continues
for thirty (30)&nbsp;days after written notice by the Executive of such loss is given to the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
a Prohibited Event occurs, <I>provided</I> that the Executive gives written notice of termination within ninety (90)&nbsp;days after
such occurrence and such Prohibited Event is not remedied within thirty (30)&nbsp;days after such notice. For this purpose, a &ldquo;Prohibited
Event&rdquo; exists if the Executive is not continuously Executive Chairman of the Board of Directors of the Company during the Term;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
the Company shall make a general assignment for benefit of creditors, or any proceeding shall be instituted by the Company seeking to
adjudicate it a bankrupt or insolvent, or seeking liquidation, winding up, reorganization, arrangement, adjustment, protection, relief,
or composition of it or its debts under any law relating to bankruptcy, insolvency or reorganization or relief of debtors, or seeking
entry of an order for relief or the appointment of a receiver, trustee, or other similar official for it or for any substantial part
of its property, or the Company shall take any corporate action to authorize any of the actions set forth above in this Section&nbsp;7(c);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
an involuntary petition shall be filed or an action or proceeding otherwise commenced against the Company seeking reorganization, arrangement
or readjustment of the Company&rsquo;s debts or for any other relief under the Federal Bankruptcy Code, as amended, or under any other
bankruptcy or insolvency act or law, state or federal, now or hereafter existing and shall remain undismissed or unstayed for a period
of thirty (30)&nbsp;days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
a receiver, assignee, liquidator, trustee or similar officer for the Company or for all or any part of its property shall be appointed
involuntarily; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
a material breach by the Company of any other material agreement with the Executive shall occur, if such breach continues uncured for
thirty (30)&nbsp;days after written notice by the Executive describing such breach is first given to the Company; <I>provided, however</I>,
that the Executive shall be permitted to terminate this Agreement if such breach is for the payment of money and continues uncured for
ten (10)&nbsp;days after written notice describing such breach is first given by the Executive to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
termination of this Agreement and the Executive&rsquo;s employment hereunder by the Executive pursuant to this Section 7 due to the occurrence
of any of the events specified herein shall only be effective if such event also results in a material change to the employment relationship
between the Executive and the Company (or any successor thereto). The foregoing provision is intended to qualify under Treasury Regulation
Section 1.409A-1(n)(2)(i) as an involuntary separation from service and shall be determined in a manner consistent therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Termination
    Following a Change in Control</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the above, during the period commencing on the six (6)&nbsp;month anniversary of a Change in Control and ending on the two
(2)&nbsp;year anniversary of such Change in Control, the Executive may terminate this Agreement upon expiration of ninety (90)&nbsp;days&rsquo;
prior written notice to the Company if &ldquo;Good Reason&rdquo; exists for the Executive&rsquo;s termination. For this purpose, termination
for &ldquo;Good Reason&rdquo; shall mean a termination by the Executive of his employment hereunder following the occurrence, without
his prior written consent, of any of the following events, unless the Company fully cures all grounds for such termination within thirty
(30)&nbsp;days after the Executive&rsquo;s notice:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
any material adverse change in the Executive&rsquo;s authority, duties, titles or offices (including reporting responsibility), or any
significant increase in the Executive&rsquo;s business travel obligations, from those existing immediately prior to the Change in Control;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
any failure by the Company to continue in effect any compensation plan in which the Executive participated immediately prior to such
Change in Control and which is material to the Executive&rsquo;s total compensation, including but not limited to the Company&rsquo;s
stock option, bonus and other plans or any substitute plans adopted prior to the Change in Control, unless an equitable arrangement (embodied
in an ongoing substitute or alternative plan) has been made with respect to such plan, or any failure by the Company to continue the
Executive&rsquo;s participation therein (or in such substitute or alternative plan) on a basis no less favorable to the Executive, both
in terms of the amount of benefits provided and the level of the Executive&rsquo;s participation relative to other participants, as existed
immediately prior to such Change in Control;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
any failure by the Company to continue to provide the Executive with benefits substantially similar to those enjoyed by the Executive
under any of the Company&rsquo;s retirement, life insurance, medical, health and accident, or disability plans, programs or arrangements
in which the Executive was participating immediately prior to such Change in Control, the taking of any action by the Company that would
directly or indirectly materially reduce any of such benefits or deprive the Executive of any perquisite enjoyed by the Executive at
the time of such Change in Control, or the failure by the Company to maintain a vacation policy with respect to the Executive that is
at least as favorable as the vacation policy (whether formal or informal) in place with respect to the Executive immediately prior to
such Change in Control; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the failure of the Company to obtain the assumption in writing of its obligation to perform this Agreement by any successor to all or
substantially all of the assets of the Company upon a merger, consolidation, sale or similar transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
termination of this Agreement and the Executive&rsquo;s employment hereunder by the Executive pursuant to this Section 8 due to the occurrence
of any of the events specified herein shall only be effective if such event also results in a material change to the employment relationship
between the Executive and the Company (or any successor thereto). The foregoing provision is intended to qualify under Treasury Regulation
Section 1.409A-1(n)(2)(i) as an involuntary separation from service and shall be determined in a manner consistent therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Severance
    and Benefit Continuation</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<I>Termination for Cause or Voluntary Termination by the Executive.</I> If the Company terminates this Agreement for Cause pursuant to
Section&nbsp;6(c) hereof, or if the Executive voluntarily terminates this Agreement other than pursuant to Section&nbsp;7 or 8 hereof
(which termination alone shall not constitute a breach of this Agreement), no severance or benefit continuation provisions shall apply;
<I>provided, however,</I> that the Executive shall have the same opportunity to continue group health benefits at the Executive&rsquo;s
expense in accordance with the Consolidated Omnibus Budget Reconciliation Act of 1985 (&ldquo;COBRA&rdquo;) as is available generally
to other employees terminating employment with the Company. All stock options and stock awards (and similar equity rights) held by the
Executive that have vested prior to such termination of this Agreement may be exercised by the Executive for a period of one hundred
eighty (180)&nbsp;days after the date of termination (subject to earlier termination in connection with a Change in Control and similar
events as provided in the applicable plan and/or award agreement), at which time they shall automatically be forfeited if not exercised.
All stock options and stock awards (and similar equity rights) that have not vested prior to such termination shall be forfeited by the
Executive. For purposes of this Agreement, an election by the Company not to renew this Agreement beyond the end of the then-current
Term shall be considered a termination of this Agreement Other Than for Cause.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<I>Termination for Death or Disability.</I> In the event of termination of this Agreement pursuant to Section&nbsp;6(a) or 6(b) by reason
of the death or disability of the Executive, in addition to the Base Salary payments and pro rata annual performance bonus provided for
in paragraph (a)&nbsp;or (b)&nbsp;of Section&nbsp;6, as applicable, the Company shall continue to provide all benefits subject to COBRA,
at its sole cost and expense, with respect to the Executive and his dependents for the maximum period provided by COBRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<I>Termination by the Company Other Than for Cause or Termination by the Executive Based on a Material Breach by the Company (Other than
Death or Disability) Outside of Change in Control Protection Period.</I> If (1)&nbsp;the Company terminates this Agreement and the Executive&rsquo;s
employment other than pursuant to Section&nbsp;6 hereof or (2)&nbsp;the Executive terminates this Agreement and his employment pursuant
to Section&nbsp;7, and in each case the termination of employment does not occur on or within two (2)&nbsp;years following the consummation
of a Change in Control, then, subject to Section 9(e):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the Company shall pay the Executive in accordance with its normal payroll practice an amount equal to the Executive&rsquo;s Base Salary
at the annualized rate in effect on the date of such termination, such payment to be made in equal monthly installments (rounded down
to the nearest whole cent) over a period of twelve (12) consecutive months following the Executive&rsquo;s Separation from Service (as
defined in Section 12) (the &ldquo;Severance Period&rdquo;), with the first installment payable, subject to Section 15(b), in the month
following the month in which the Executive&rsquo;s Separation from Service occurs;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all Company employee benefit plans and programs (including, but not limited to, the plans and programs set forth in Section&nbsp;3(f)),
other than participation in any Company tax-qualified retirement plan and any bonus, equity or other incentive plans and programs, applicable
to the Executive shall be continued for the Severance Period (or, if such benefits are not available, or cannot be provided due to applicable
law, the Company shall pay the Executive a lump sum cash amount equal to the after-tax economic equivalent thereof, <I>provided</I> that,
with respect to any benefit to be provided on an insured basis, such lump sum cash value shall be the present value of the premiums expected
to be paid for such coverage, and with respect to other benefits, such value shall be the present value of the expected cost to the Company
of providing such benefits, and that, in all events, such payment shall be made within ninety (90) days following the Executive&rsquo;s
Separation from Service). In the case of all benefits subject to COBRA, the Company shall continue to provide such benefits at its expense
with respect to the Executive and his dependents for the maximum period provided by COBRA; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
all stock options and awards of restricted stock (and similar equity rights), to the extent outstanding and vested on the date of such
termination of this Agreement, shall remain fully exercisable through their respective original maximum terms (subject to earlier termination
in connection with a Change in Control and similar events as provided in the applicable plan and/or award agreement) and otherwise in
accordance with their respective terms and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<I>Involuntary Termination Other Than for Cause, Termination by the Executive Based on a Material Breach by the Company or for Good Reason
(Other than Death or Disability), or Nonrenewal by the Company During the Change in Control Protection Period</I>. If (1)&nbsp;the Company
terminates this Agreement and the Executive&rsquo;s employment other than pursuant to Section&nbsp;6 hereof or (2)&nbsp;the Executive
terminates this Agreement and his employment pursuant to Section&nbsp;7 or 8, and in each case the termination of employment occurs on
or within two (2)&nbsp;years of the consummation of a Change in Control of the Company, then, subject to Section 9(e):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the Company shall pay the Executive a cash lump sum equal to one (1)&nbsp;times the Executive&rsquo;s Base Salary at the annualized rate
in effect on the date of such termination, such payment to be made, subject to Section 15(b), in the month following the month in which
the Executive&rsquo;s Separation from Service occurs;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all Company employee benefit plans and programs (including, but not limited to, the plans and programs set forth in Section&nbsp;3(f),
other than participation in any Company tax-qualified retirement plan) applicable to the Executive shall be continued for one (1)&nbsp;year
from the date of such termination of employment (or, if such benefits are not available, or cannot be provided due to applicable law,
the Company shall pay the Executive a lump sum cash amount equal to the after-tax economic equivalent thereof, <I>provided</I> that<I>,
</I>with respect to any benefit to be provided on an insured basis, such lump sum cash value shall be the present value of the premiums
expected to be paid for such coverage, and with respect to other benefits, such value shall be the present value of the expected cost
to the Company of providing such benefits and that, in all events, such payment shall be made within ninety (90) days following the Executive&rsquo;s
Separation from Service). In the case of all benefits subject to COBRA, the Company shall continue to provide such benefits at its sole
cost and expense with respect to the Executive and his dependents for the maximum period provided by COBRA; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
all stock options and awards of restricted stock (and similar equity rights), to the extent then vested and outstanding (after giving
effect to any accelerated vesting pursuant to Section&nbsp;3 (c)&nbsp;hereof), shall remain fully exercisable through their respective
original maximum terms (provided that, after giving effect to such accelerated vesting and providing the Executive a reasonable opportunity
to exercise such vested options and similar awards, such options and awards shall be subject to earlier termination in connection with
a Change in Control and similar events as provided in the applicable plan and/or award agreement) and otherwise in accordance with their
respective terms and conditions as if no Change in Control had occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The payments provided in Section&nbsp;9(c) and 9(d) are intended as enhanced severance for a termination by the Company without Cause,
or a termination by the Executive in the circumstances provided. As a condition of receiving such payments, the Executive or his legal
representatives, should he have such, shall first execute and deliver to the Company within twenty-one (21) days (or such other period
required under applicable law) following such termination of employment a general release of all claims against the Company, its Affiliates,
agents and employees (other than any claims or rights pursuant to the Agreement or pursuant to equity or employee benefit plans), in
a form and substance satisfactory to the Company, and shall not revoke such release within any revocation period provided under applicable
law (the &ldquo;Release Period&rdquo;). In connection with such release by the Executive, the Company shall execute and deliver a comparable
release of claims against the Executive within the same period following such termination of employment, and may revoke such release
if the Executive revokes his release within any revocation period provided under applicable law. Notwithstanding the foregoing, the Executive
may elect to forego the severance payments provided herein, in which event neither party shall be required to execute a release of the
other. Notwithstanding the foregoing provisions of this Section 9(e), no release to be granted by the Executive shall be required to
cause the Executive to release the Company from, waive, or forego in any way any of the Executive&rsquo;s rights to indemnification under
the applicable provisions of the Certificate of Incorporation or By-laws of the Company or any then-existing agreement between the Company
and the Executive with respect thereto; and no release to be granted by the Company hereunder shall apply to any obligation of the Executive
pursuant to this Agreement or any act of fraud or material dishonesty by the Executive. In addition, any release provided by one party
to the other party pursuant to this Section 9(e) shall be null and void if the other party does not timely provide the release required
hereunder (or, in the case of the release provided by the Company, if the Executive revokes his release within any revocation period
provided by applicable law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cooperation</U>.
    </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the termination of his employment, the Executive agrees to cooperate with, and assist, the Company to ensure a smooth transition in management
and, if requested by the Company, to make himself available to consult during regular business hours at mutually agreed upon times for
up to a three (3)&nbsp;month period thereafter. At any time following the termination of his employment, the Executive will provide such
information as the Company may request with respect to any Company- related transaction or other matter in which the Executive was involved
in any way while employed by the Company. The Executive further agrees, during the Term of this Agreement and thereafter, to assist and
cooperate with the Company in connection with the defense or prosecution of any claim that may be made against, or by, the Company or
its Affiliates, in connection with any dispute or claim of any kind involving the Company or its Affiliates, including providing testimony
in any proceeding before any arbitral, administrative, judicial, legislative or other body or agency. The Executive shall be entitled
to reimbursement for all properly documented expenses reasonably incurred in connection with rendering transition services under this
Section, including, but not limited to, reimbursement for all reasonable travel, lodging, meal expenses and legal fees, and the Executive
shall be entitled to a per diem amount for his services equal to his then most recent annualized Base Salary under this Agreement, divided
by two hundred forty (240)&nbsp;(business days).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
    Mitigation</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Executive shall not be required to mitigate the amount of any payment provided for hereunder by seeking other employment or otherwise,
nor shall the amount of any payment provided for hereunder be reduced by any compensation earned by the Executive as the result of employment
by another employer after the date of termination of employment by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Definitions</U>.
    </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used herein, the following terms have the following meaning:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;Affiliate&rdquo; means and includes any person, corporation or other entity controlling, controlled by or under common control
with the person, corporation or other entity in question, determined in accordance with Rule 12b-2 under the Securities Exchange Act
of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;Change in Control&rdquo; means the occurrence of any of the following events:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Any Person, other than the Company, its Affiliates or any Company employee benefit plan (including any trustee of such plan acting as
trustee), is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing more than fifty percent
(50%)&nbsp;of the combined voting power of the then outstanding securities entitled to vote generally in the election of directors (&ldquo;Voting
Securities&rdquo;) of the Company; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Individuals who constitute the Board (the &ldquo;Incumbent Directors&rdquo;), as of the beginning of any twenty-four (24)&nbsp;month
period commencing with the Effective Date of this Agreement, cease for any reason to constitute at least a majority of the directors.
Notwithstanding the foregoing, any individual becoming a director subsequent to the beginning of such period, whose election or nomination
for election by the Company&rsquo;s stockholders, was approved by a vote of at least two-thirds (2/3)&nbsp;of the directors then comprising
the Incumbent Directors, shall be, considered an Incumbent Director; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Consummation by the Company of a recapitalization, reorganization, merger, consolidation or other similar transaction (a &ldquo;Business
Combination&rdquo;), with respect to which all or substantially all of the individuals and entities who were the Beneficial Owners of
the Voting Securities immediately prior such Business Combination (the &ldquo;Incumbent Shareholders&rdquo;) do not, following consummation
of all transactions intended to constitute part of such Business Combination, Beneficially Own, directly or indirectly, fifty percent
(50%)&nbsp;or more of the Voting Securities of the corporation, business trust or other entity resulting from or being the surviving
entity in such Business Combination (the &ldquo;Surviving Entity&rdquo;), in substantially the same proportion as their ownership of
such Voting Securities immediately prior to such Business Combination; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Consummation of a complete liquidation or dissolution of the Company, or the sale or other disposition of all or substantially all of
the assets of the Company, other than to a corporation, business trust or other entity with respect to which, following consummation
of all transactions intended to constitute part of such sale or disposition, more than fifty percent (50%)&nbsp;of the combined Voting
Securities is then Beneficially Owned, directly or indirectly, by the Incumbent Shareholders in substantially the same proportion as
their ownership of the Voting Securities immediately prior to such sale or disposition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this definition, the following terms shall have the meanings set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
&ldquo;Beneficial Owner&rdquo; shall have the meaning set forth in Rule 13d-3 under the Exchange Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
&ldquo;Exchange Act&rdquo; shall mean the Securities Exchange Act of 1934, as amended; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)
&ldquo;Person&rdquo; shall have the meaning as used in Sections 13(d) and 14(d) of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a transaction shall not constitute a Change in Control unless it is a &ldquo;change in the ownership or effective control&rdquo;
of the Company, or a change &ldquo;in the ownership of a substantial portion of the assets&rdquo; of the Company within the meaning of
Section 409A of the U.S. Internal Revenue Code of 1986, as amended (&ldquo;Code Section 409A&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;Company&rsquo;s Field of Interest&rdquo; means the primary businesses of the Company as described in the Company&rsquo;s then
two most recent Annual Reports on Form 10-K filed by the Company with the Securities and Exchange Commission (subject to any further
description of such businesses that may be included in any Quarterly Reports on Form 10-Q or Current Reports on Form 8-K thereafter filed
by the Company with the Securities and Exchange Commission) or as determined from time to time by the Board during the Term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
As used herein, a &ldquo;Separation from Service&rdquo; occurs when the Executive dies, retires, or otherwise has a termination of employment
with the Company that constitutes a &ldquo;separation from service&rdquo; within the meaning of Treasury Regulation Section 1.409A-1(h)(1),
without regard to the optional alternative definitions available thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representations
    by Executive</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Executive represents and warrants that he has full right, power and authority to execute this Agreement and perform his obligations hereunder
and that this Agreement has been duly executed by the Executive and such execution and the performance of this Agreement by the Executive
do not and will not result in any conflict, breach or violation of or default under any other agreement or any judgment, order or decree
to which the Executive is a party or by which he is bound. The Executive acknowledges and agrees that any material breach of the representations
set forth in this Section&nbsp;13 will constitute Cause under Section&nbsp;6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Tax
    Withholding</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may withhold from any amounts payable under this Agreement (such as Federal, state, local or foreign taxes) as shall be required
to be withheld pursuant to any applicable law or regulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
    409A Compliance</U>. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
It is intended that any amounts payable under this Agreement shall either be exempt from or comply with Code Section 409A (including
the Treasury regulations and other published guidance relating thereto) so as not to subject the Executive to payment of any additional
tax, penalty or interest imposed under Code Section 409A. The provisions of this Agreement shall be construed and interpreted to avoid
the imputation of any such additional tax, penalty or interest under Code Section 409A yet preserve (to the nearest extent reasonably
possible) the intended benefit payable to the Executive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If the Executive is a &ldquo;specified employee&rdquo; within the meaning of Treasury Regulation Section 1.409A-1(i) as of the date of
the Executive&rsquo;s Separation from Service, the Executive shall not be entitled to any payment or benefit pursuant to Section 9(c)
or 9(d) until the earlier of (i) the date which is six (6) months after his Separation from Service for any reason other than death,
or (ii) the date of the Executive&rsquo;s death. The provisions of this Section 15(b) shall only apply if, and to the extent, required
to avoid the imputation of any tax, penalty or interest pursuant to Code Section 409A. Any amounts otherwise payable to the Executive
upon or in the six (6) month period following the Executive&rsquo;s Separation from Service that are not so paid by reason of this Section
15(b) shall be paid (without interest) as soon as practicable (and in all events within thirty (30) days) after the date that is six
(6) months after the Executive&rsquo;s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty
(30) days, after the date of the Executive&rsquo;s death).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
To the extent that any benefits pursuant to Section 9(c)(ii) or 9(d)(ii) or reimbursements pursuant to Section 3(d) or 3(e) are taxable
to the Executive, any reimbursement payment due to the Executive pursuant to any such provision shall be paid to the Executive on or
before the last day of the Executive&rsquo;s taxable year following the taxable year in which the related expense was incurred. The benefits
and reimbursements pursuant to such provisions are not subject to liquidation or exchange for another benefit and the amount of such
benefits and reimbursements that the Executive receives in one taxable year shall not affect the amount of such benefits or reimbursements
that the Executive receives in any other taxable year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Notwithstanding anything to the contrary in this Agreement, to the extent required to comply with Code Section 409A, a termination of
employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of amounts
or benefits upon or following a termination of employment unless such termination is also a &ldquo;separation from service&rdquo; within
the meaning of Code Section 409A and, for purposes of any such provision of this Agreement, references to a &ldquo;resignation,&rdquo;
&ldquo;termination,&rdquo; &ldquo;termination of employment&rdquo; or like terms shall mean separation from service. For purposes of
Section 409A of the Code, each payment made under this Agreement shall be designated as a &ldquo;separate payment&rdquo; within the meaning
of the Section 409A of the Code. Notwithstanding anything to the contrary in this Agreement, to the extent required to comply with Code
Section 409A, if the Release Period spans two calendar years, any severance payments to which the Executive may be entitled pursuant
to Section 9(c) or 9(d) shall be paid on the first regularly scheduled payroll date that occurs in the second calendar year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Arbitration</U>.
    </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto shall attempt in good faith to resolve all claims, disputes and other disagreements arising hereunder by negotiation.
In the event that a dispute between the parties hereto cannot be resolved within thirty (30)&nbsp;days of written notice from one party
to the other party, such dispute shall, at the request of either party, after providing written notice to the other party, be submitted
to arbitration in Lawrenceville, New Jersey in accordance with the arbitration rules of the American Arbitration Association then in
effect. The notice of arbitration shall specifically describe the claims, disputes or other matters in issue to be submitted to arbitration.
The parties hereto shall jointly select a single arbitrator who shall have the authority to hold hearings and to render a decision in
accordance with the arbitration rules of the American Arbitration Association. If the parties hereto are unable to agree within ten (10)&nbsp;days,
the arbitrator shall be selected by the Chief Judge of the Circuit Court for Howard County. The discovery rights and procedures provided
by the Federal Rules of Civil Procedure shall be available and enforceable in the arbitration proceeding. The written decision of the
arbitrator so appointed shall be conclusive and binding on the parties hereto and enforceable by a court of competent jurisdiction. The
expenses of the arbitration shall be borne equally by the parties hereto to the arbitration, and each party shall pay for and bear the
cost of its or his own experts, evidence and legal counsel, unless the arbitrator rules otherwise in the arbitration. Each party agrees
to use its or his best efforts to cause a final decision to be rendered with respect to the matter submitted to arbitration within sixty
(60)&nbsp;days after its submission. Notwithstanding the foregoing, the Company shall be free to pursue its rights and remedies under
Section&nbsp;5 hereof and pursuant to Exhibit A hereto in any court of competent jurisdiction, without regard to the arbitral proceedings
contemplated by this Section&nbsp;16.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notices</U>.
    </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
notices, requests, consents and other communications required or permitted to be given hereunder or contemplated or in connection herewith
shall be in writing and shall be deemed to have been duly given if sent by private overnight mail service (delivery confirmed by such
service), registered or certified mail (return receipt requested and received), telecopy (confirmed receipt by return fax from the receiving
party) or if delivered personally, as follows (or to such other address as either party shall designate by notice in writing to the other
in accordance herewith):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celsion
Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
Lenox Drive, Suite 100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
NJ 08648</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Chairman of the Compensation Committee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
609-896-9100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
609-896-2200</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt; text-indent: -34.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
copies to:</FONT></P>

<P STYLE="font: 10pt/13pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/13pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Baker&nbsp;&amp;&nbsp;McKenzie
LLP</FONT></P>

<P STYLE="font: 10pt/13pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">452
Fifth Avenue</FONT></P>

<P STYLE="font: 10pt/13pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10018</FONT></P>

<P STYLE="font: 10pt/13pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Steven G. Canner</FONT></P>

<P STYLE="font: 10pt/13pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
212-626-4884</FONT></P>

<P STYLE="font: 10pt/13pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:
212-310-1884</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Executive:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
Tardugno</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Indemnification
    and Limitation of Liability.</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the protections afforded by Article Ninth of the Amended and Restated Certificate of Incorporation,
as may be amended from time to time, of the Company, and Article VI of the Amended and Restated Bylaws, as may be amended from time to
time, of the Company are available to the Executive throughout the Term and thereafter, in accordance with their respective terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>General</U>.
    </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New Jersey applicable to agreements
made and to be performed entirely in New Jersey.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
This Agreement, together with the agreement set forth in Annex A hereto, sets forth the entire agreement and understanding of the parties
hereto relating to the subject matter hereof, and supersedes all prior agreements, arrangements and understandings, written or oral,
relating to the subject matter hereof, including without limitation the Prior Employment Agreement. This Agreement hereby supersedes
and replaces the Prior Employment Agreement in its entirety effective as of the Effective Date, and the Prior Agreement shall terminate
and have no further force or effect as of the Effective Date. No representation, promise or inducement has been made by either party
hereto that is not embodied in this Agreement, and neither party hereto shall be bound by or liable for any alleged representation, promise
or inducement not so set forth. Notwithstanding the foregoing, in the event that the provisions hereof shall conflict with the terms
of any stock option grant agreement, stock award agreement or similar document granting stock options, warrants or similar rights, then
the terms hereof shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
This Agreement may be amended, modified, superseded, canceled, renewed or extended, and the terms or covenants hereof may be waived,
only by a written instrument executed by the parties hereto, or in the case of a waiver, by the party hereto waiving compliance. The
failure of a party hereto at any time or times to require performance of any provision hereof shall in no manner affect the right at
a later time to enforce the same. No waiver by a party hereto of the breach of any term or covenant contained in this Agreement, whether
by conduct or otherwise, or any one or more or continuing waivers of any such breach, shall constitute a waiver of the breach of any
other term or covenant contained in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective legal representatives, heirs,
distributees, successors and permitted assigns. The Company may not assign its rights and obligation under this Agreement without the
prior written consent of the Executive, except to a successor to substantially all the Company&rsquo;s business that expressly assumes
the Company&rsquo;s obligations hereunder in writing. For purposes of this Agreement, &ldquo;successors&rdquo; shall mean any successor
by way of share exchange, merger, consolidation, reorganization or similar transaction, or the sale of all or substantially all of the
assets of the Company. The Executive may not assign, transfer, alienate or encumber any rights or obligations under this Agreement, except
by will or operation of law, <I>provided</I> that the Executive may designate beneficiaries to receive any payments permitted under the
terms of the Company&rsquo;s benefit plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page follows.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, each of the parties hereto has executed this Agreement under its or his seal effective as of the date first above
written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
  <TR>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SEAL]</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celsion
    Corporation</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Robert W. Hooper</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print
    Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    W. Hooper</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and Chairman of Compensation Committee</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SEAL]</FONT></P></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    <I></I></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael H. Tardugno</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael H. Tardugno</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Chairman of
    the Board of Directors</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
page to Employment Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employee
Proprietary Information and Ownership of Inventions Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Attached)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-1</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 41.25pt; width: 102pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Celsion
Appoints Dr. Corinne Le Goff as President and Chief Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Michael
H. Tardugno appointed Executive Chairman of the Board</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAWRENCEVILLE,
N.J., July 19, 2022 &mdash; Celsion Corporation (NASDAQ: CLSN</B>), a clinical-stage company focused on DNA-based immunotherapy and next-generation
vaccines, today announced that the Company&rsquo;s Board of Directors has appointed biopharmaceutical leader Corinne Le Goff, Pharm D,
MBA, as President and Chief Executive Officer and Director, effective July 18, 2022. Current President and CEO Michael H. Tardugno will
continue to serve as Executive Chairman of Celsion&rsquo;s Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Le Goff brings decades of global healthcare leadership experience to the Company across a range of therapeutic areas including oncology,
vaccines, immunology, CNS and cardio-metabolism. She brings a wealth of experience in developing and launching successful drugs from
her tenure at both large, pharmaceutical companies and small, innovative biotech companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;On
behalf of the Board of Directors and the entire Celsion team, I would like to warmly welcome Corinne to Celsion,&rdquo; said Michael
H. Tardugno, Chairman of Celsion&rsquo;s Board of Directors. &ldquo;She adds tremendous depth of knowledge and joins us at a key inflection
point in our evolution, as we work to rapidly advance our GEN-1 program for the treatment of advanced-stage ovarian cancer and build
a proprietary vaccine platform based on our PLACCINE technology. Corinne&rsquo;s skills and expertise in development and commercialization
of therapeutics in oncology and immunology make her uniquely qualified to lead us on the next stage of growth. We look forward to her
astute guidance.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Corinne Le Goff stated, &ldquo;I am thrilled and honored to join as President and CEO of Celsion at this pivotal point for the Company.
Celsion has an impressive portfolio of assets that address substantial unmet needs in the current vaccine and oncology landscapes. I
look forward to working together with my new colleagues and the Board to realize upon the tremendous opportunities and efficiently advance
these life-improving solutions for patients through clinical development, regulatory approval and commercialization.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to her Celsion appointment, Dr. Corinne Le Goff most recently served as the Chief Commercial Officer of Moderna, was responsible for
developing the global presence and capabilities necessary to ensure the global distribution of Moderna&rsquo;s COVID-19 vaccine. She
also led the development of the mRNA platform long-term commercial strategy. Dr. Le Goff joined Moderna from Amgen, where she served
as President of the U.S. Business, driving the growth strategy with increased contributions from Repatha&reg; and Aimovig&reg;. During
her nearly 6-year tenure at Amgen, she also served as Senior Vice President of Global Product Strategy &amp; Commercial Innovation and
as President of the Europe Region overseeing 48 markets. Dr. Le Goff was actively engaged with the policy community and advocates for
innovative, high-quality and affordable healthcare. She represented Amgen as a member of the Healthcare Leadership Council. Prior to
joining Amgen, Dr. Le Goff held a number of senior international roles at Roche, including President of Roche France, a major affiliate
of the Roche Group, and Global Product Strategy Head of Neuroscience &amp; Rare Diseases. Early in her career, Dr. Le Goff spent 11 years
in various leadership roles at Sanofi and Pfizer in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Le Goff is currently a Director of Acticor Biotech, of Longboard Pharmaceuticals and of EuroAPI. She also served on the Board of Directors
of CFAO, a trading company that operates in Africa, for 6 years until December 2020. Dr. Le Goff earned a PhD in pharmaceutical sciences
from Rene Descartes University in Paris and an MBA from Sorbonne University and INSEAD. She also holds qualifications from Northwestern
University and the Hong Kong University of Science and Technology. She received the distinction of being named a Chevalier de la L&eacute;gion
d&rsquo;Honneur in 2014. She holds a U.S. patent, and was recently recognized by Forbes Magazine as one of the women over the age of
50 who are changing the world.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Celsion Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celsion
is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including
immunotherapies and DNA-based therapies; and a platform for the development of nucleic acid vaccines currently focused on SARS-CoV2.
The company&rsquo;s product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. Celsion
also has two platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies.
Both are novel synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection. For more information
on Celsion, visit <U>www.celsion.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Celsion
wishes to inform readers that forward-looking statements in this release are made pursuant to the &ldquo;safe harbor&rdquo; provisions
of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward-looking statements involve risks and
uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical
trials; the uncertainties of and difficulties in analyzing interim clinical data; the significant expense, time, and risk of failure
of conducting clinical trials; the need for Celsion to evaluate its future development plans; possible acquisitions or licenses of other
technologies, assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed
from time to time in Celsion&rsquo;s periodic reports and prospectuses filed with the Securities and Exchange Commission. Celsion assumes
no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or
otherwise.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Celsion
Investor Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B>Jeffrey W. Church<BR>
Executive Vice President, CFO and Corporate Secretary<BR>
609-482-2455<BR>
<U>jchurch@celsion.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">#
# #</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
MM1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!
M"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=8
M65IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ
M_]H #@0!  (1 Q$$   _ /RJHHHH _5.BBBBBBB@ HHHHHHHH ******** "
MBBBBBBB@ HHHHHHHH ******** "BBBBBBB@ HHHHHHHH ******** "BBBB
MBBB@ HHHHHHHH ******VO#7@_7O&5U+:^']%U'7+F%/,DATVTDN'1<XW%4!
M(&3UKH/^%$?$K_HGGBK_ ,$ES_\ $5R5,7AZ4N2I4BGYM(?*WL@HJ.6:.)<N
MZH/]IL5']NMO^?B/_OH5PM%7-2TV\T74)['4+6:QO;=S'-;7,9CDC8<%65@"
M"/0U3KJC)25UL(L44Q6$B[E.Y3T(I]%%%%, HHHHJUI^FW6JW*P6D#W$K?PH
M,UI^%?"MSXJOO)B_=P)S+,W11_C7MFAZ#9>'[-;>SA\L?Q/_ !N?4FOT/AG@
M_$9[_M%5\E%=>K\H_P">WKJ>!F6;4\#[D5S3[=O4****X#1?A \JK)JEUY?_
M $QM^6_%CQ^E=7;^!_#FC0^;)9P;4^])=-N'X[N*K>,/B#:^'-UM;A;J_P#[
MG\$?^]_A7DVL>(-0UZ;S;VX:7T3HB_0=*^UQ^-X:X6;PV$PZK5EO?6S\Y.]G
MY17K8\:A1S',_P!Y5J.$'VT^Y?YA1117J%YXZ\+:/\EM#'<,.UK  /S.!6)=
M?%JW;*PZ)&5]9)!_(+7F]3V]G<7C;8+>28^D:%OY5\56XVSG$RY,/RTUVC!/
M\U(]B&2X2FKU+R\VW^E@HHHKK+CXA6]U_KO#NFR>[)S^>*S)M:T6Z^_H/D-W
M>UNF7]&!%4_^$7UC_H$WW_@,_P#A5>XT>_L^;BRN8/\ KI$R_P Q7CXC,<WJ
MIRQ,+K^]2A^;@==/#X2.E-V])/\ S"BBBI)H=,E_X][BXA;^[<1@K_WTIS_X
M[5%E"L0&##U6FT5\W4JJIJHI>E_\[?<>E&+CUN%%%%%%%%8%A11111110 44
M444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111110 444444
M44 %%%%%%%% !11111110 44444444 %%%%%%3V]O)>3)#"C2S2,$2-%)9F)
MP  .I-?H%^RW_P $N=4\6P67B3XLS7&@:7)B2+PY;_+>S*>1Y[_\L0?[H^;_
M '#7SF=\09=P]A_K&85.5=%O*7DEU_)=6C6G2E5=HH***Y_4?$RQ,T=M\[=Y
M&^[^%?"'A7P=KOCC5HM+\.Z-?Z[J4GW+33K9YY6]]J@G%?4'@'_@EY\;_&4:
M3:C8:3X1MVYSK-\#)C_<A$A!]FQ7ZZ?#GX4^$?A'H,>C>#O#UCX?T]<9CLXL
M-*1_%(YRTC?[3$FNLK^<\W\8,=5DX970C3CWG[TON5DO3WO4]2&!BE[[N;DD
MT<"[G947U;BLV?Q)90_=9I3_ +*_XXKE+BZENI-\LC2-_M5%7YDZ-_P1OOI%
M5M6^*5O;OD;HK/0VE!&><.TZX_[YK6NO^"-NG-#BV^*MU%)_>ET)9!CZ"X7^
M=?I!17PTO$KBF4N;ZW;_ +<I_P#R)O\ 5:/;\SI&\6#^&V_[Z;_ZU,7Q<_\
M%:K_ -_/_K5SU%?E/XJ_X(^^.+%'?P]XZT+5\<A=0MYK-C_WSYHS^-?-_P 3
MOV*/C/\ "6.6XUKP+J%QI\?)O])VWT(7^\QB+%!_O@5^]%%>]E_BUGV%DOK2
MA6CYKE?R<;+\&9RP=-[:'41>*X&^_#*O^[@_X5H6VKV=UPDR[O[K<']:X>BO
MYI:*_=3]H;]AOX:?M#6MQ=7FF1^'/$[@F/7](C6.9G/.9D&%F&>N[YO1A7Y%
M?M&?LQ^,_P!F7Q=_9/B:T6;3YV+:?K-JI-K>H/[I/W7'\2-R/<8)_H+A?CO+
M.)_W-/\ =UOY)=?\+^U^#\K'FUL/.CJ]4>C45Q&GZU<V#;5;S(O[C?TKJ]/U
M*+48=\1Y'WD;JM>04445^D'*7******** "BBBBBBB@ HHHHHHHH *******
M* "BBBBBBB@ HHHK[V_X(^_\EO\ &?\ V+I_]*8:_62OR;_X(^_\EO\ &?\
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M%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%%
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M+']D8?<EC=ONR*Q^7USC!SBOS5_9!_X*/7?P1\$7_A3QW;7WB;2;"V+:"\#
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M^CMHW=/1IW/E(\02GCGA.3EMU?7^EJ1VNF7-Y\T4+,OKT'YFKC>&;W;]V/\
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M=TC?,(VZ+]:^]OBI^U;\)O@M<2VOBWQOIUEJ,?WM.@9KJZ4]@T,09ES_ +0
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M_P#Z>_\ R'_]>C_A#_\ I[_\A_\ UZZ.BOTM_P"'S/\ U2#_ ,N;_P"XZ/\
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M\5_\></^_P#TKEZ_ 3]K[_DZ/XI_]C%>?^C37D%>O_M??\G1_%/_ +&*\_\
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M@C#KS+;E[MZMVMKRG=*E1I4[2V-G6O$"JK0VK;F/RM(O\/TJGI.OR6>V*?\
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M>8_^EU#V\#_#?K_D9OB'_D#W'_ ?_0A7%UVGB'_D#W'_  '_ -"%<77XP_\
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MV<UH_P !ZZ'J-POFRW6V4_PLQ_I3K'5+FQO%L[TY4\!VZC/3FNDKE_%3*UU
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M_**?^W9'<:+_ ,$\OA]I_B<-'XE5-$@D2YYE^V):'SL_[0"RYK*^#MY-8_\
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MX^7'S9%;%%?>.C_M,?#:T_X)J/\ "J3Q'M\>M;SQC2/L-R>6U1IU_?"/RO\
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M%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%%
M!11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !111
M11110 44444444 %%%%%%%% !11111110 44444444 %%%%?0O[$OC#5_ OQ
MANM2T.[^PWO]E7$7F^4DGREXLC#@CMZ5PG[1.M7GB3XW>,=4U*;[3?7-ZTDL
MNU5W-M7G"@ ?@***^0H4J:X@JU5%<SII7MK:ZTOV-VW[)+S,[6XEFLU5QD;Q
MW^M6;&-8K.)5&%"]***\UHHHKZ\P+%%%%%%%% !11111110 44444444 %%%
M%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%
M% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !1
M1111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111
/110 44444444 %%%%?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>ex99-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0 0 0pt"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-2_001.jpg" ALT="" STYLE="height: 41.25pt; width: 102pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Celsion
Corporation Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAWRENCEVILLE,
N.J., July 19, 2022 -- Celsion Corporation (NASDAQ: CLSN</B>), a clinical-stage company focused on DNA-based
immunotherapy and next-generation vaccines, today announced that the Compensation Committee of the Company&rsquo;s Board of
Directors approved the grant of (i) inducement stock options (the &ldquo;Inducement Option Grants&rdquo;) to purchase a total of
177,000 shares of common stock, and (ii) restricted stock grants (the &ldquo;Inducement Stock Grants&rdquo;) totaling 53,000 shares
of common stock to Corinne Le Goff, the Company&rsquo;s new President and Chief Executive Officer, effective July 18,
2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Inducement Option Grants have an exercise price per share equal to $1.95, the closing price of Celsion&rsquo;s common stock as reported
by Nasdaq on July 18, 2022. The Inducement Option Grants vest 25% on the one-year anniversary of Dr. Le Goff&rsquo;s first day of employment
with the Company and thereafter vest in quarterly installments so all Inducement Option Grants will be fully vested and exercisable as
of July 18, 2026, subject to Dr. Le Goff&rsquo;s continued service relationship with the Company on each such date. Each Inducement Option
Grant has a ten-year term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the Inducement Stock Grants will vest on the one-year anniversary of Dr. Le Goff&rsquo;s first date of employment with the Company
and are subject to Dr. Le Goff&rsquo;s continued service relationship with the Company on such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the stock options and the stock grants is an inducement material to Dr. Le Goff entering into employment with Celsion Corporation
in accordance with Nasdaq listing Rule 5635(c) (4).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Celsion Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celsion
is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including
immunotherapies and DNA-based therapies; and a platform for the development of nucleic acid vaccines currently focused on SARS-CoV2.
The company&rsquo;s product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. Celsion
also has two platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies.
Both are novel synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection. For more information
on Celsion, visit <U>www.celsion.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Celsion
wishes to inform readers that forward-looking statements in this release are made pursuant to the &ldquo;safe harbor&rdquo; provisions
of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward-looking statements involve risks and
uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical
trials; the uncertainties of and difficulties in analyzing interim clinical data; the significant expense, time, and risk of failure
of conducting clinical trials; the need for Celsion to evaluate its future development plans; possible acquisitions or licenses of other
technologies, assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed
from time to time in Celsion&rsquo;s periodic reports and prospectuses filed with the Securities and Exchange Commission. Celsion assumes
no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or
otherwise.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Celsion
Investor Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey
W. Church<BR>
Executive Vice President, CFO and Corporate Secretary<BR>
609-482-2455<BR>
<U>jchurch@celsion.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">#
# #</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex99-2_001.jpg
<TEXT>
begin 644 ex99-2_001.jpg
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M=?I!17PTO$KBF4N;ZW;_ +<I_P#R)O\ 5:/;\SI&\6#^&V_[Z;_ZU,7Q<_\
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M* "BBBBBBB@ HHHK[V_X(^_\EO\ &?\ V+I_]*8:_62OR;_X(^_\EO\ &?\
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M%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%%
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M+']D8?<EC=ONR*Q^7USC!SBOS5_9!_X*/7?P1\$7_A3QW;7WB;2;"V+:"\#
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M^CMHW=/1IW/E(\02GCGA.3EMU?7^EJ1VNF7-Y\T4+,OKT'YFKC>&;W;]V/\
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M=TC?,(VZ+]:^]OBI^U;\)O@M<2VOBWQOIUEJ,?WM.@9KJZ4]@T,09ES_ +0
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M_P#Z>_\ R'_]>C_A#_\ I[_\A_\ UZZ.BOTM_P"'S/\ U2#_ ,N;_P"XZ/\
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M\5_\></^_P#TKEZ_ 3]K[_DZ/XI_]C%>?^C37D%>O_M??\G1_%/_ +&*\_\
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M@C#KS+;E[MZMVMKRG=*E1I4[2V-G6O$"JK0VK;F/RM(O\/TJGI.OR6>V*?\
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M>8_^EU#V\#_#?K_D9OB'_D#W'_ ?_0A7%UVGB'_D#W'_  '_ -"%<77XP_\
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MV<UH_P !ZZ'J-POFRW6V4_PLQ_I3K'5+FQO%L[TY4\!VZC/3FNDKE_%3*UU
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M_**?^W9'<:+_ ,$\OA]I_B<-'XE5-$@D2YYE^V):'SL_[0"RYK*^#MY-8_\
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MX^7'S9%;%%?>.C_M,?#:T_X)J/\ "J3Q'M\>M;SQC2/L-R>6U1IU_?"/RO\
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M%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%%
M!11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !111
M11110 44444444 %%%%%%%% !11111110 44444444 %%%%?0O[$OC#5_ OQ
MANM2T.[^PWO]E7$7F^4DGREXLC#@CMZ5PG[1.M7GB3XW>,=4U*;[3?7-ZTDL
MNU5W-M7G"@ ?@***^0H4J:X@JU5%<SII7MK:ZTOV-VW[)+S,[6XEFLU5QD;Q
MW^M6;&-8K.)5&%"]***\UHHHKZ\P+%%%%%%%% !11111110 44444444 %%%
M%%%%% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%
M% !11111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !1
M1111110 44444444 %%%%%%%% !11111110 44444444 %%%%%%%% !11111
/110 44444444 %%%%?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>clsn-20220719.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWamHObP9z5Z8KekhvWB5bSmq7yojQE85WiNkvGpG0X8I -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:CLSN="http://celsion.com/20220719" elementFormDefault="qualified" targetNamespace="http://celsion.com/20220719">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://celsion.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="clsn-20220719_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="clsn-20220719_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>clsn-20220719_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>clsn-20220719_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://celsion.com/role/Cover" xlink:href="clsn-20220719.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://celsion.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140127014267008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 19, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 19,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CELSION
CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000749647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-1256615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">997
    Lenox Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lawrenceville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08648-2311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(609)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">896-9100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLSN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="clsn-20220719.xsd" xlink:type="simple"/>
    <context id="From2022-07-19to2022-07-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <startDate>2022-07-19</startDate>
            <endDate>2022-07-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-07-19to2022-07-19">0000749647</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-07-19to2022-07-19">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-07-19to2022-07-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-07-19to2022-07-19">2022-07-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-07-19to2022-07-19">CELSION CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-07-19to2022-07-19">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-07-19to2022-07-19">001-15911</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-07-19to2022-07-19">52-1256615</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-07-19to2022-07-19">997     Lenox Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-07-19to2022-07-19">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-07-19to2022-07-19">Lawrenceville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-07-19to2022-07-19">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-07-19to2022-07-19">08648-2311</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-07-19to2022-07-19">(609)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-07-19to2022-07-19">896-9100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-07-19to2022-07-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-07-19to2022-07-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-07-19to2022-07-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-07-19to2022-07-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-07-19to2022-07-19">Common     stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-19to2022-07-19">CLSN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-19to2022-07-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-07-19to2022-07-19">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ML@.9AL FUB)@N8>?'U)<L>4WJ-]JMVD+P:->Z9G>)8!3&2B=*)VS79&%@7>
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M2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R#/;
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ ;$KS5&60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( &Q*\U16ED?J[@   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( &Q*\U297)PC$ 8
M )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ ;$KS5*#R(:AF!   *Q$  !@              ("!#0@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( &Q*\U2?H!OPL0(
M .(,   -              "  :D,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /T3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://celsion.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>clsn-20220719.xsd</File>
    <File>clsn-20220719_lab.xml</File>
    <File>clsn-20220719_pre.xml</File>
    <File>ex10-1.htm</File>
    <File>ex10-2.htm</File>
    <File>ex99-1.htm</File>
    <File>ex99-2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "clsn-20220719_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clsn-20220719_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "clsn-20220719.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "CLSN",
   "nsuri": "http://celsion.com/20220719",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-07-19to2022-07-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://celsion.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-07-19to2022-07-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://celsion.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001493152-22-019765-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-019765-xbrl.zip
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MJ C31?=(UZT]X-Y.6WSC?KDWL-HC_P-02P,$%     @ ;$KS5(%E2U5&2P
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MVQ'>YP]@<7K6:0S6QN?=,?HN,)HY+:Z[=H_ZE2,,X(._U/)K_?X/_AN=#7R
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M<NBGS54HB7(OLNPP8. 5<I"*_<&$L"_$2PI(QD16*1H7'8#DTA@>553QK:,
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M;^+PI/2P^FKN-AW)HD#6<D9_S9/' %8QT*@MG<[8&T@*$Q8O6:R^]4$=A=T
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M1F/XSVX9:FPFUA3$$K519(EU3O7CP=(JT-#LV/6"M!1=B!<3[K6MXY;!.@D
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MCV6;.#'1)O6@0=K+ "T++) 9[[B%-8^([-(*%9\<K8=P0?>CH'LE2L[*J^&
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M[6$Z;5'Q*A,:KC.\T*-$ZABNQMW4%G-B#-?V740$6FC ;S9<5+)G:T(US.
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ML1R&Q.P=N=[1#25@Z/;RH >:,<#39G/L&,[E=GT1SA9<3X=#J&$FIJ_[7?=
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M3_8>?=_"Z8YFB%63U.#Q@T@$!]JU!!FF@0A+2]+<)NV4/BEA_,H60C*&.6:
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M2NS8H<$.$DT.]XS1ER;(BE%G#&;7ECUA"A9M[CC&A/=TU#R#=IP^X/A1-!K
MAM(F#68BD;J.(L&)&XKV4ANVUHY?FF(W&&Y0.B_3"X*<@'S(T1B"%0;SO])H
MET1E*7D36!Z7EC.V/]!%AF'PAW9P3:9I52N9:8RBAJ!O]*P1F$5-F7-F;U[K
M!13XIN3[DAVJ9X"1R1M5(OVXT. FE UG2RHBG-#94EIU<#R2I$0S.*H\OUP6
MQ 3F*?C +JRS<IYS[OO6>LEWUL.6>S]OZ!\P X):%JY9OYX->;R_=WQ\%PR+
MFSK:5RJK"*OWRI*VWY>Q/WWZ>#AXJ_+B2_"Z1,A)\*E)X=*#_75?IN#'_(:#
M=W\/]I\\>OADQ>,_.GABRT'6,(T3C/20+P<'Z3Q*L4[;)7@R;;GA!]*)*CA3
MF9J?@^,'7L;^T]TG3Q_M/KU'&_>*"7R&@S>H\GX.?CT#E[Z9YL5_QWRC]L R
M6.=DVF[ZT<-[*,GN8!)L0,7%G.-V6S6REM&^C#ZC6?:7:#9_%OP:_V^5_R=5
M 3C-]V4"#X\/D<AN4I\')\1D>%\&#I\<#OY5E)_#X-V_4/4=K%IYK&WHKM;X
M5&,^,/CK7O J @=HU>V)UJT K38;#@X/#G<?'3[:??CDR</[LA6LQ?0V[/$>
M_#?=:GV;UZW0[HGPO'L'R "GMKIK/:9<4:9PW-&5"/Y:3";W9=P_0,!ZP35;
M113;?S2E!3<SL/WD6P/;:Y=5SW][<0H6_"PG-,CMJ1$P*O@V!;\PTL#?MVDT
M3K.TONJ$SV'KVP'T%;<OO)\QN@V,HGMT.$NIRVJNR*UULX<(\0<"63E!H9"I
MX%V*!:P6X$1E]?B@CXK8<9+@%4>A8RFH/,W=/H3#051IX+&F).^00H>=MHGX
M CV"?YPN??W+JRRZK"APO>0]H-5[7D0@(8<'M5W<5)^713.ELMFZCZ):E_Z4
MBM 3X0+$6%IJD 8\%$:"(/H?!TIPYS/K'9Q,XJME;6M.R\ 1#Y>"([98B%MC
M(38&]["))_%[F-,/8%)_SQB0IQN& ?FKRA%JNWX,R&-8RZWYNGJRK[-S[-C0
M4_HW)?@$6ZAH>_D,58)+3A8!]]%0-+5_M=BK#M[?(6C4D'$IUZ:J1,&KCPTI
M,E:CY]@_(*-: ?ND-11.;\_9&IBE6N<,2S>GBN IMN; 'D*7O-D@DC4:V9
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M<]B;G=K>2V>>[>(H\PR%R%)0!BB-J_],W/7JV*V?"6NVQA&AZXYO..@>WHO
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MJ#K49+(]L7EL@F)NWV6"D.UWZB^HOC'?APTW:N!5IH_H;W &SH%H&+J-YR'
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MA'&M471"KE[,SSD<'.BBP+@DPQU+"4N4YO#%A,"WT_R\R"B]EO-834D8@N/
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M@XKHOH^W+B./?M?)R$T6:$T@Y]H DIAZ>\\Q ".X&&N:4&KVG*TTU+EL&T=
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MR)&/R#,-FX0'YV"QMOM>$[X$5PQAVRN<[$+3.<,_VM6Y)3N2DI)H%(K_;<
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M/*$)16ED'->K,,7,1.RE(#5)2C1HX"'7;R.;:B)(Y*ABMX>S^Z[SACMF6X>
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MAEWZC?O"7?,^_YK&LTAEP\%95";--"_NQ![?=4UM%PG:18*V(A+T;,LC0:?
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M6)'!\VT :C;P%#P:OB;:) V]=$F\#%_6B3"#0XO4R</H8A%O<'\]"K3 S*)
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MUI;O4GW/<_>RV8>'A\Q#,>.(7C9?J52R0RR3TH7VAHGE"KE</OOUM-DV^FQ
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M RL-+61A'V#4V'?D$OR!GZ* -M2GT2U+!TY0.S+:]3#ORC?ZFD1%@:(X&'?
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M65>:'?\/4$L! A0#%     @ ;$KS5*A!_ZTH P  J L  !$
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M4$L! A0#%     @ ;$KS5"3ZWK;N#0  7SD   H              ( !C*P
M &5X.3DM,2YH=&U02P$"% ,4    " !L2O-45KL'_/D(   G)@  "@
M        @ &BN@  97@Y.2TR+FAT;5!+ 0(4 Q0    ( &Q*\U3'31>G*QL
M 'C%   +              "  </#  !F;W)M."UK+FAT;5!+!08     "  (
+ -X!   7WP     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
